Other disorders of nervous system

G6_NEUROOTH

nervous system disease: A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G98, G99* Cause of death: ICD-10 — G98, G99* 2 out of 7 registries used, show all original rules.	3037
4. Check minimum number of events None	3037
5. Include endpoints None	3037
6. Filter based on genotype QC (FinnGen only)	2729

Control definitions (FinnGen only)

Control exclude: G6_OTHNEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	G6_NEUROOTH
CONTROL_EXCLUDE	G6_OTHNEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G98\|G99
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G98\|G99
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other disorders of nervous system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	13637	6281	7307
Only index persons	12774	5937	6837
Unadjusted period prevalence (%)
Whole population	0.19	0.18	0.20
Only index persons	0.24	0.22	0.26
Median age at first event (years)
Whole population	58.90	59.38	58.44
Only index persons	58.38	58.76	58.05

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2729	1367	1362
Unadjusted period prevalence (%)	0.55	0.49	0.62
Median age at first event (years)	60.36	58.61	62.12

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2816: Matched controls
28160

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M47.9

ICD-10 Finland

Spondylosis, unspecified

10.6

321.6

374

400

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

1410.5

307.7

652

M48.0

ICD-10 Finland

Spinal stenosis

11.4

307.7

1327

2047

N03AX16

ATC

[U] pregabalin

5.7

307.7

1420

4254

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

52.0

307.7

477

110

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

54.4

307.7

188

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

6114.6

307.7

882

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

18.1

307.7

885

696

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

21.8

307.7

679

405

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

193.0

307.7

520

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

9.4

307.7

720

996

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

746.9

307.7

388

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

27.3

307.7

600

277

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

13.2

307.7

647

621

N03AX12

ATC

[U] gabapentin; oral

5.6

307.7

1069

2775

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

1680.0

307.7

426

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

687.0

307.7

361

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

14.6

307.7

326

251

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

6.2

307.7

804

1703

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

5.0

307.7

926

2501

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

20.8

307.7

253

133

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

15.4

296.1

266

189

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

5.4

289.3

683

1567

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

7.0

264.8

444

732

ABC50

NOMESCO Finland

Decopression of cervical spinal canal and nerve roots

74.6

250.6

135

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

5.8

244.7

505

1018

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

19.1

239.3

191

107

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.3

233.5

773

2293

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

8.9

227.4

299

372

N02AX02

ATC

tramadol; systemic, rectal

3.5

222.5

1774

9237

M03BX01

ATC

baclofen; systemic

12.6

216.2

218

187

N06AX21

ATC

duloxetine; oral

4.2

205.5

660

1899

N02BF01

ATC

gabapentin; oral

4.4

204.2

623

1725

M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

106.9

200.1

103

WX408

NOMESCO Finland

General anesthesy, balanced

3.3

197.2

1153

4901

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

10.6

193.0

218

221

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

17.4

190.0

158

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

6.6

188.6

324

542

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

16.3

174.6

150

G99.2*M47.0

ICD-10 Finland

Anterior spinal and vertebral artery compression syndromes

1823.1

171.6

165

M50.3

ICD-10 Finland

Other cervical disc degeneration

8.8

169.2

221

271

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

85.5

156.9

N02BF02

ATC

pregabalin; oral

4.6

156.1

416

1026

L01

ICPC

Neck symptom/complaint

3.3

154.9

745

2759

M54.2

ICD-10 Finland

Cervicalgia

4.2

148.0

446

1206

NA1AD

NOMESCO Finland

Cervical spine CT examination

5.3

144.3

311

641

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.2

141.8

724

2763

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

4.0

136.1

447

1283

AA1AD

NOMESCO Finland

CT of head and brain

2.7

135.5

1064

5111

M54.4

ICD-10 Finland

Lumbago with sciatica

3.0

132.4

788

3266

XKD06

NOMESCO Finland

Physiologic investigation of micturition

6.5

130.9

223

367

M54.1

ICD-10 Finland

Radiculopathy

5.5

130.3

267

525

L28

ICPC

Limited function/disability (L)

2.9

129.6

803

3397

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

17.1

128.3

107

N06AA09

ATC

amitriptyline; systemic

3.7

127.6

472

1466

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

6.4

125.9

219

368

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

5.6

125.7

253

489

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

40.5

123.4

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.1

122.9

633

2408

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

6.2

119.8

214

369

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

6.1

110.2

200

350

G98

ICD-10 Finland

Other disorders of nervous system, not elsewhere classified

559.3

109.6

108

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

6.5

109.2

185

302

L83

ICPC

Neck syndrome

12.6

108.3

107

L86

ICPC

Back syndrome with radiating pain

4.0

108.0

335

917

G82.2

ICD-10 Finland

Paraplegia, unspecified

25.7

107.4

XKC03

NOMESCO Finland

Water cystometry

5.8

105.1

200

366

WX402

NOMESCO Finland

General anaesthesia

2.5

105.1

884

4297

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

103.8

1044

5501

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

9.1

103.3

128

146

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

7.0

103.2

161

241

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.8

103.1

353

1034

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

7.7

102.2

147

201

M54.5

ICD-10 Finland

Low back pain

2.3

102.1

1273

7353

G99.0*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic autonomic neuropathy

1013.8

100.8

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

12.5

100.6

100

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

12.1

94.8

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

12.8

94.3

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.2

93.8

1490

9413

M03BX02

ATC

tizanidine; oral

2.3

91.0

1971

14056

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.4

89.1

354

1139

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.9

88.7

479

1845

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

87.3

693

3239

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.2

87.3

389

1342

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

85.9

623

2788

R20.2

ICD-10 Finland

Paraesthesia of skin

3.6

85.7

309

933

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

11.2

84.5

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

842.9

84.0

L03

ICPC

Low back symptom/complaint

2.2

83.9

1011

5647

ABC10

NOMESCO Finland

Microsurgical excision of cervical intervertebral disc displacement

23.1

83.9

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

9.3

82.3

100

111

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

5.1

81.2

177

365

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

4.6

79.8

198

455

N02AJ06

ATC

codeine and paracetamol; systemic

2.1

77.7

1429

9318

N03AX09

ATC

lamotrigine; oral

4.3

76.9

210

520

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

13.7

76.0

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.7

75.7

491

2069

M03BC01

ATC

orphenadrine (citrate); systemic

2.3

75.2

771

4000

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

5.5

75.1

148

279

N03AE01

ATC

clonazepam; systemic

3.6

74.8

265

789

N06AX16

ATC

venlafaxine; oral

2.6

74.6

521

2276

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

12.7

74.5

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

73.8

1564

10665

N02AA05

ATC

oxycodone; systemic

2.3

73.8

701

3518

M43.1

ICD-10 Finland

Spondylolisthesis

4.2

73.7

204

510

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

15.1

73.5

SPAT1262

SPAT

Handing over of treatment supplies

2.4

72.9

645

3137

N81

ICPC

Injury nervous system other

26.8

72.7

G99.0*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic autonomic neuropathy

716.1

71.4

SPAT1229

SPAT

Assessment of need for aid

3.1

70.4

316

1089

XX2CT

NOMESCO Finland

Other injection with CT guidance

27.1

70.1

WX704

NOMESCO Finland

Intubation

3.0

69.7

350

1286

M79.6

ICD-10 Finland

Pain in limb

2.0

69.4

1401

9316

M47.82

ICD-10 Finland

Other spondylosis, cervical region

3.9

68.5

216

593

S18

ICPC

Laceration/cut

2.0

67.6

1539

10635

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.2

67.3

188

473

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.0

66.7

323

1162

R52.2

ICD-10 Finland

Other chronic pain

4.1

66.7

192

494

N06AA10

ATC

nortriptyline; systemic

5.6

65.5

126

232

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

26.9

65.5

N18

ICPC

Paralysis/weakness

6.0

65.4

117

201

UKC02

NOMESCO Finland

Cystoscopy

2.3

64.8

598

2946

ABB00

NOMESCO Finland

Excision of lesion of spinal canal

22.7

64.3

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

64.3

770

4213

A01

ICPC

Pain general/multiple sites

2.7

64.3

400

1643

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.1

62.8

277

943

N02BE01

ATC

paracetamol; systemic, rectal

3.5

62.4

2636

22769

XKD03

NOMESCO Finland

Urethral pressure profilometry

5.3

61.7

126

245

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

319.8

61.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

60.4

974

5917

M01AH05

ATC

etoricoxib; oral

2.0

60.3

1912

14535

G992, M480,

ICD-10 Finland

+∞

59.6

L89

ICD-10 Finland

Decubitus ulcer and pressure area

5.7

59.3

113

206

J01FF01

ATC

clindamycin; systemic

2.0

59.3

895

5305

ABC63

NOMESCO Finland

Decompression of thoracic spinal cord

95.1

59.1

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.1

58.7

125

252

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

8.1

58.5

100

A02BC02

ATC

pantoprazole; systemic

2.0

58.4

2080

16366

J01MA02

ATC

ciprofloxacin; systemic

1.9

57.9

1218

8060

WX110

NOMESCO Finland

Infiltration anesthesia

2.1

57.9

2114

16752

G992, M472,

ICD-10 Finland

+∞

57.5

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.8

57.5

181

496

C03CA01

ATC

furosemide; systemic

2.0

57.4

942

5735

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.0

57.4

102

174

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

15.4

57.2

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

11.1

56.5

ZXD05

NOMESCO Finland

Urgent procedure

2.0

56.4

909

5494

S97

ICPC

Chronic ulcer skin

3.0

56.4

273

979

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

19.4

56.3

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

56.1

644

3442

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

55.5

752

4272

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

54.8

476

2271

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

54.8

989

6198

A28

ICPC

Limited function/disability NOS

2.1

54.2

603

3180

ACC51

NOMESCO Finland

Release of median nerve

2.8

54.0

306

1193

SPAT1263

SPAT

Sampling

1.9

53.9

1215

8163

WX725

NOMESCO Finland

Noninvasive ventilation

3.1

52.9

240

829

R4120

NOMESCO Finland

Occupational therapy

2.9

52.8

261

946

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.1

52.7

241

836

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.9

52.6

872

5297

M48.9

ICD-10 Finland

Spondylopathy, unspecified

11.7

52.5

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

10.2

52.3

SPAT1153

SPAT

Removal of sutures

1.9

52.2

1003

6391

R4110, ,

SPAT

2.2

51.3

502

2512

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

50.8

1243

8521

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

21.4

50.6

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

50.6

1087

7158

NF1AA

NOMESCO Finland

Hip X-ray examination

2.5

50.4

347

1488

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.6

50.2

175

513

N06AX11

ATC

mirtazapine; oral

1.8

49.7

1036

6748

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

49.6

420

1977

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

49.4

416

1953

M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

80.2

49.1

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

9.7

48.7

R1250

NOMESCO Finland

Evaluation of functional capability

4.5

48.6

120

274

R33

ICD-10 Finland

Retention of urine

2.6

48.3

305

1254

A02BC05

ATC

esomeprazole; systemic

1.8

48.2

1232

8516

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

7.5

48.0

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

47.3

344

1512

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

10.8

47.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

47.0

433

2108

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.5

46.9

116

265

R42

ICD-10 Finland

Dizziness and giddiness

2.0

46.9

698

4064

M54.3

ICD-10 Finland

Sciatica

2.9

46.9

232

840

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.0

46.6

223

792

NA2AD

NOMESCO Finland

Thoracic spine CT examination

9.5

46.3

R52.1

ICD-10 Finland

Chronic intractable pain

7.6

46.3

SPAT1216

SPAT

Assessment of functional ability

2.1

46.1

497

2574

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

4.9

45.7

102

214

M01AB05

ATC

diclofenac; systemic, rectal

1.8

45.2

1934

15404

M01AH02

ATC

rofecoxib; oral

2.2

44.9

430

2124

R51.80

ICD-10 Finland

Headache

2.2

44.8

460

2335

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

12.0

44.6

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

17.0

44.5

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

44.3

379

1787

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

5.3

42.9

168

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

152.4

42.9

G83.4

ICD-10 Finland

Cauda equina syndrome

13.5

42.5

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.5

42.5

153

458

TKC20

NOMESCO Finland

Catheterisation of bladder

2.7

42.5

245

961

N30.0

ICD-10 Finland

Acute cystitis

2.1

42.2

502

2690

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

42.2

439

2237

G44.2

ICD-10 Finland

Tension-type headache

2.2

42.2

413

2055

ABC53

NOMESCO Finland

Decompression of thoracic spinal canal and nerve roots

69.6

42.1

NA1BG, ,

SPAT

4.9

41.7

199

J01DB01

ATC

cefalexin; oral

2.0

41.7

2352

20126

R53

ICD-10 Finland

Malaise and fatigue

1.9

41.4

725

4427

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

40.5

363

1742

A02BC01

ATC

omeprazole; systemic

1.8

40.0

791

5003

A06AD11

ATC

lactulose; oral

2.1

39.9

463

2454

N05CF01

ATC

zopiclone; oral

1.8

39.8

948

6329

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

5.7

39.7

132

G47.3

ICD-10 Finland

Sleep apnoea

1.8

39.5

762

4782

J01MA12

ATC

levofloxacin; systemic

1.9

39.5

597

3470

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.7

39.2

229

903

SPAT1301

SPAT

No procedures

1.8

39.2

885

5815

A10AB05

ATC

insulin aspart; parenteral

2.5

39.1

269

1149

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

7.5

39.0

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.6

39.0

138

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

8.1

38.9

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.5

38.7

134

391

A10AB04

ATC

insulin lispro; parenteral

3.7

38.6

123

339

H02AB06

ATC

prednisolone; systemic

1.7

38.6

1388

10333

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

38.5

250

1039

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

38.4

1006

6883

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.0

38.2

178

622

Z50.1

ICD-10 Finland

Other physical therapy

2.8

38.1

204

769

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.4

38.1

272

1181

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.0

38.1

110

283

N02AC04

ATC

dextropropoxyphene; oral

3.4

37.9

139

421

M01AH01

ATC

celecoxib; oral

1.9

37.7

559

3222

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

37.6

743

4684

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

37.6

352

1716

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

37.4

866

5714

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

37.2

470

2564

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

37.2

795

5127

A46

ICD-10 Finland

Erysipelas

2.0

37.0

491

2726

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

36.9

1065

7457

XKD00

NOMESCO Finland

Uroflowmetry

1.9

36.9

527

2998

R52.9

ICD-10 Finland

Pain, unspecified

2.2

36.8

343

1668

A10AB01

ATC

insulin (human); parenteral

3.6

36.8

125

360

N28

ICPC

Limited function/disability (N)

4.5

36.8

204

A10AC01

ATC

insulin (human); parenteral

2.5

36.7

246

1037

R4110

NOMESCO Finland

Physiotherapy

1.7

36.5

839

5518

R06.0

ICD-10 Finland

Dyspnoea

1.7

36.5

822

5377

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

36.4

833

5471

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

11.3

36.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

36.1

540

3118

N29

ICPC

Neurological sympt/complt other

4.4

35.9

216

M01AB55

ATC

diclofenac, combinations; oral

2.5

35.8

235

981

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

35.4

781

5072

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

6.9

35.2

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

35.1

189

714

R5110, ,

SPAT

2.2

35.1

306

1448

R13

ICD-10 Finland

Dysphagia

2.4

35.0

249

1078

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.1

35.0

377

1939

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.3

34.8

283

1300

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.2

34.7

143

465

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

34.7

243

1045

TAB00

NOMESCO Finland

Lumbar puncture

3.1

34.6

153

519

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.4

34.6

126

380

L02

ICPC

Back symptom/complaint

2.2

34.4

321

1561

L12

ICPC

Hand/finger symptom/complaint

1.9

34.2

522

3028

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

341.2

34.0

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

34.0

458

2550

A10AA01, ,

ATC

3.9

33.9

100

261

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.7

33.9

195

762

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

33.9

560

3330

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

3.3

33.6

130

407

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.1

33.6

142

469

G54.0

ICD-10 Finland

Brachial plexus disorders

3.8

33.5

103

277

G992, M511,

ICD-10 Finland

+∞

33.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

33.3

591

3590

M54.6

ICD-10 Finland

Pain in thoracic spine

2.4

33.3

246

1083

L17

ICPC

Foot/toe symptom/complaint

1.7

33.3

910

6244

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.0

33.2

148

504

SPAT1254

SPAT

Administration of medicine

2.0

33.2

424

2316

A10AA02, ,

ATC

3.5

33.0

116

342

NAG52

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, 2-3 vertebraea

75.1

32.9

H3603, E103,

ICD-10 Finland

6.7

32.8

M25.5

ICD-10 Finland

Pain in joint

1.7

32.8

957

6673

ZZH40

NOMESCO Finland

Substitute of bone

6.2

32.7

M43.0

ICD-10 Finland

Spondylolysis

4.3

32.7

202

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.7

32.7

690

4409

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.0

32.5

420

2301

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

6.5

32.4

M79.1

ICD-10 Finland

Myalgia

1.9

32.4

449

2519

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.2

32.4

311

1528

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

32.4

231

1001

R60.0

ICD-10 Finland

Localized oedema

2.0

32.4

408

2217

S14.0

ICD-10 Finland

Concussion and oedema of cervical spinal cord

55.0

32.3

ACC53

NOMESCO Finland

Release of ulnar nerve

4.6

32.3

175

M79.7

ICD-10 Finland

Fibromyalgia

3.4

32.2

121

372

Z3226

NOMESCO Finland

Physiotherapist

1.8

32.1

532

3161

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.1

32.0

137

456

N05BA01

ATC

diazepam; systemic, rectal

2.0

31.9

389

2089

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

31.8

765

5060

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

31.7

366

1927

W19

ICD-10 Finland

Unspecified fall

2.2

31.6

308

1521

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

31.5

457

2601

UJF32

NOMESCO Finland

Coloscopy

1.7

31.3

783

5231

N07BC02

ATC

methadone; systemic

9.2

31.3

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.5

31.1

172

A10AE04

ATC

insulin glargine; parenteral

2.1

31.0

318

1602

M01AE02

ATC

naproxen; oral, rectal

1.6

31.0

1548

12234

N06AB04

ATC

citalopram; systemic

1.8

30.7

580

3580

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.8

30.6

262

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

6.1

30.2

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

30.0

612

3861

A10AE05

ATC

insulin detemir; parenteral

2.6

29.9

181

725

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

29.7

377

2049

M54

ICD-10 Finland

Dorsalgia

2.0

29.7

365

1962

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

6.9

29.7

G95.9

ICD-10 Finland

Disease of spinal cord, unspecified

107.9

29.7

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.3

29.6

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

29.5

405

2262

G82.5

ICD-10 Finland

Tetraplegia, unspecified

50.6

29.4

M50.8

ICD-10 Finland

Other cervical disc disorders

7.7

29.3

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

29.1

197

833

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

28.9

229

1038

B01AC04

ATC

clopidogrel; oral

1.9

28.9

446

2585

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

28.8

729

4867

ZXC95

NOMESCO Finland

Use of surgical navigator

4.9

28.8

134

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

28.8

109

337

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.0

28.7

129

442

J01EA01

ATC

trimethoprim; systemic

1.7

28.6

666

4349

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.2

28.6

245

1148

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.8

28.5

242

G04BD12

ATC

mirabegron; oral

1.9

28.4

387

2153

G45.3

ICD-10 Finland

Amaurosis fugax

49.1

28.4

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

8.7

28.4

M01AB51

ATC

indometacin, combinations; oral, rectal

3.5

28.4

101

300

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

28.3

260

1253

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

9.3

28.3

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

28.2

253

1208

N04BC05

ATC

pramipexole; oral

2.2

28.0

251

1198

G95.2

ICD-10 Finland

Cord compression, unspecified

64.7

28.0

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

27.9

195

836

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

27.9

1776

14674

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

27.7

417

2397

M50

ICD-10 Finland

Cervical disc disorders

6.8

27.6

H04AA01

ATC

glucagon; nasal, parenteral

4.1

27.6

189

TAB20

NOMESCO Finland

Epidural puncture

6.2

27.5

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

25.7

27.5

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

27.3

401

2285

M01AE51

ATC

ibuprofen, combinations; systemic

4.3

27.3

169

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

27.2

282

1423

N05AH04

ATC

quetiapine; oral

1.8

27.2

475

2855

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.9

27.2

X58

ICD-10 Finland

Exposure to other specified factors

1.8

27.2

434

2540

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

27.1

117

391

M86.6

ICD-10 Finland

Other chronic osteomyelitis

10.4

27.1

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.9

27.1

214

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

27.1

386

2179

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

26.9

950

6861

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

4.8

26.9

126

A02BC03

ATC

lansoprazole; oral

1.6

26.8

808

5621

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.3

26.7

104

SPAT1211

SPAT

Application of soft bandage

2.1

26.6

264

1310

N03AF01

ATC

carbamazepine; oral, rectal

2.6

26.6

166

675

R11

ICD-10 Finland

Nausea and vomiting

2.1

26.3

253

1240

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.2

26.1

230

1089

N05BA04

ATC

oxazepam; oral

1.6

26.1

710

4810

G95.0

ICD-10 Finland

Syringomyelia and syringobulbia

+∞

26.1

G99.0

ICD-10 Finland

Autonomic neuropathy in endocrine and metabolic diseases

+∞

26.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

25.9

1422

11290

T90

ICPC

Diabetes non-insulin dependent

1.6

25.8

742

5095

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

27.2

25.8

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.2

25.8

222

1042

L08

ICPC

Shoulder symptom/complaint

1.6

25.7

691

4666

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

136.3

25.6

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

25.6

107

351

OAB50, ,

SPAT

2.1

25.6

270

1371

J01DA01

ATC

[U] cefalexin

1.5

25.5

1648

13526

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.1

25.5

266

1345

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.1

25.5

M41.9

ICD-10 Finland

Scoliosis, unspecified

4.7

25.5

128

L13

ICPC

Hip symptom/complaint

1.7

25.5

585

3792

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

25.4

302

1601

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

25.4

395

2289

M01AX17

ATC

nimesulide; oral

1.6

25.4

690

4669

B01AB05

ATC

enoxaparin; parenteral

1.6

25.4

890

6399

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.1

25.4

258

1292

M50.2

ICD-10 Finland

Other cervical disc displacement

28.7

25.4

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.6

25.2

147

578

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

6.0

25.1

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.3

25.0

299

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

24.9

1129

8582

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

24.9

781

5467

ZXD35

NOMESCO Finland

Usual procedure

3.0

24.7

113

391

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

24.6

224

1074

TKC22

NOMESCO Finland

Catheterisation instruction

3.2

24.4

304

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

24.3

223

1073

M01AC06

ATC

meloxicam; systemic, rectal

1.5

24.2

1011

7541

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

9.7

24.1

G56.4

ICD-10 Finland

Causalgia

8.5

24.0

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

24.0

392

2304

9211

FHL

Exploration or removal of diskusprolapse

3.3

23.9

272

Z01.2

ICD-10 Finland

Dental examination

1.5

23.9

1243

9699

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

23.9

721

4993

R35

ICD-10 Finland

Polyuria

2.1

23.8

227

1108

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.1

23.7

325

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

8.2

23.5

C07AB07

ATC

bisoprolol; oral

1.5

23.4

1364

10876

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.8

23.4

113

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.7

23.4

446

2742

M02AA07

ATC

piroxicam; topical

1.5

23.3

981

7311

G82.1

ICD-10 Finland

Spastic paraplegia

47.1

23.3

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

8.9

23.3

TAC99

NOMESCO Finland

Other blockade for chronic pain

6.1

23.3

NF1DA

NOMESCO Finland

X-ray of hips

3.3

23.1

268

R15

ICD-10 Finland

Faecal incontinence

3.0

23.1

105

362

J02AC01

ATC

fluconazole; systemic

1.5

23.0

975

7274

C08CA01

ATC

amlodipine; oral

1.5

22.9

1095

8375

T89

ICPC

Diabetes insulin dependent

2.6

22.8

133

523

N06AB10

ATC

escitalopram; oral

1.7

22.8

511

3281

SPAT1167

SPAT

Insertion of urinary catheter

2.9

22.8

107

376

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

5.2

22.7

R51

ICD-10 Finland

Headache

2.5

22.7

149

621

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.6

22.6

208

ABC21

NOMESCO Finland

Anterior decompression of cervical spine with insertion of interbody fixating implant

121.0

22.6

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

6.6

22.6

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.8

22.5

363

2124

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

22.4

1226

9622

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.1

22.4

304

G04BD08

ATC

solifenacin; oral

2.2

22.4

202

965

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

6.2

22.4

NHQ40

NOMESCO Finland

Amputation of toe

3.9

22.3

173

M54.8

ICD-10 Finland

Other dorsalgia

2.5

22.3

142

583

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.4

22.3

165

726

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

22.2

760

5404

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.3

22.2

270

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.4

22.0

241

N99

ICPC

Neurological disease other

4.4

22.0

127

S06.0

ICD-10 Finland

Concussion

1.9

22.0

295

1627

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.3

21.9

262

R4180

NOMESCO Finland

Podiatric therapy

4.0

21.8

158

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

5.0

21.8

L14

ICPC

Leg/thigh symptom/complaint

2.0

21.8

249

1300

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.7

21.7

115

431

Z43.5

ICD-10 Finland

Attention to cystostomy

6.7

21.7

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

21.7

279

1518

WX002

NOMESCO Finland

Sedation and analgesia

1.6

21.6

538

3543

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

7.2

21.6

WX882

NOMESCO Finland

High dependency care

3.1

21.6

311

H3600, E103,

ICD-10 Finland

4.9

21.6

P01AB01

ATC

metronidazole; oral, rectal

1.5

21.5

1047

8009

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

3.8

21.5

178

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

21.4

406

2488

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

21.3

335

1943

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.0

21.3

238

1233

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.1

21.3

298

H02AB04

ATC

methylprednisolone; systemic

1.7

21.2

397

2423

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

5.5

21.2

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

8.5

21.0

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

21.0

1741

14744

R02

ICPC

Shortness of breath/dyspnoea

1.7

21.0

390

2375

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

8.1

20.9

R55

ICD-10 Finland

Syncope and collapse

1.9

20.9

301

1699

G992M, ,

ICD-10 Finland

+∞

20.9

U04

ICPC

Incontinence urine

2.2

20.8

180

845

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.4

20.8

220

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.5

20.8

128

517

NA1CG, ,

SPAT

6.9

20.8

ABB10

NOMESCO Finland

Resection of lesion of spinal canal

37.5

20.8

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.8

20.7

106

390

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

20.7

249

1323

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.3

20.7

251

SPAT1172

SPAT

Guidance concerning hydration

3.4

20.5

222

M53.2

ICD-10 Finland

Spinal instabilities

5.2

20.5

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

6.0

20.4

SPAT1312

SPAT

General health counselling

1.5

20.4

786

5716

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

20.3

194

947

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.4

20.3

143

615

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.9

20.2

158

L29

ICPC

Musculoskeletal sympt/complt other

1.9

20.2

267

1465

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.6

19.9

116

456

A04

ICPC

Weakness/tiredness general

1.7

19.8

406

2537

G992, M501,

ICD-10 Finland

+∞

19.8

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

19.8

294

1675

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

19.7

122

494

R5599

NOMESCO Finland

Other rehabilitation service

2.9

19.7

344

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

19.7

201

1007

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

19.6

342

2044

WX290

NOMESCO Finland

Other blockage of nerve

1.4

19.6

1210

9644

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.9

19.5

285

1615

S12.2

ICD-10 Finland

Fracture of other specified cervical vertebra

4.9

19.4

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

19.4

986

7566

J01CA08

ATC

pivmecillinam; oral

1.5

19.4

926

7020

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

19.3

448

2891

SPAT1310

SPAT

Counselling related to known health issue

1.5

19.3

814

6019

N03AF02

ATC

oxcarbazepine; oral

2.8

19.3

365

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

19.2

1003

7734

R39.1

ICD-10 Finland

Other difficulties with micturition

2.7

19.2

106

406

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

19.2

715

5152

J01CA04

ATC

amoxicillin; systemic

1.5

19.1

2174

19402

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.8

19.1

339

D32.1

ICD-10 Finland

Benign neoplasm: Spinal meninges

20.2

19.0

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

19.0

173

829

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

19.0

258

1428

PA7BD

NOMESCO Finland

CT angiography of neck and brain

4.4

19.0

108

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.2

18.9

239

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

18.9

301

1751

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

4.1

18.8

130

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.1

18.8

185

914

C01DA14

ATC

isosorbide mononitrate; oral

1.7

18.7

399

2518

E0000UV, ,

ATC

1.4

18.7

1075

8430

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

18.7

190

950

WX213

NOMESCO Finland

Lower leg blockade

4.8

18.7

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

18.7

171

822

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

18.6

607

4245

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.9

18.6

140

G04CA02

ATC

tamsulosin; oral

1.5

18.6

676

4842

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.5

18.5

182

P03

ICPC

Feeling depressed

1.9

18.5

226

1207

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.0

18.5

218

1150

SPAT1260

SPAT

Consultation of another employee

1.6

18.5

454

2971

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

18.4

509

3428

205

Kela drug reimbursment

Chronic hypertension

1.5

18.3

702

5080

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

18.3

203

1048

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

6.6

18.3

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.0

18.3

197

1007

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

7.5

18.2

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

18.2

231

1250

WX892

NOMESCO Finland

Monitored bed care

2.0

18.1

218

1158

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

18.0

179

888

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

17.8

130

568

M48

ICD-10 Finland

Other spondylopathies

7.3

17.8

A10BA02

ATC

metformin; oral

1.5

17.8

790

5886

N06

ICPC

Sensation disturbance other

4.8

17.8

NA1BM

NOMESCO Finland

Cervical spine MRI examination with 3 Tesla magnet

22.9

17.7

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

17.7

476

3183

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.2

17.6

157

746

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

17.5

213

1135

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

181.1

17.5

N05CD07

ATC

temazepam; oral

1.7

17.5

312

1873

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

17.5

144

663

N06AX26

ATC

vortioxetine; oral

2.0

17.5

187

953

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.9

17.4

273

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

17.4

140

639

ZXA00

NOMESCO Finland

Right side

1.5

17.3

691

5033

NBG10

NOMESCO Finland

Acromioplastia

2.7

17.3

340

D17

ICPC

Incontinence of bowel

4.4

17.3

NAW00

NOMESCO Finland

Repair of wound dehiscence in surgery of spine or neck

24.2

17.3

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.2

17.3

216

L84

ICPC

Back syndrome without radiat pain

2.2

17.2

148

694

NG2AA

NOMESCO Finland

Patella X-ray examination

2.6

17.2

382

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.2

17.2

222

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

17.1

192

995

H25.8

ICD-10 Finland

Other senile cataract

1.7

17.1

308

1856

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.5

16.9

105

427

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

16.9

304

1831

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

16.9

136

621

R07.3

ICD-10 Finland

Other chest pain

1.8

16.8

285

1687

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.2

16.8

151

721

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.0

16.7

257

M47.0

ICD-10 Finland

Anterior spinal and vertebral artery compression syndromes

63.7

16.7

U07

ICPC

Urine symptom/complaint other

1.8

16.7

246

1395

ZZH31

NOMESCO Finland

Bone allograft, small pieces

4.4

16.6

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

16.6

178

908

K59.0

ICD-10 Finland

Constipation

2.1

16.6

153

738

R06.4

ICD-10 Finland

Hyperventilation

3.8

16.5

129

Z3231

NOMESCO Finland

Registered nurse

1.5

16.5

698

5137

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

16.4

367

R4120, ,

SPAT

3.6

16.4

153

XA402

NOMESCO Finland

ENMG

2.9

16.3

277

SPAT1255

SPAT

Intravenous administration of medicine

2.0

16.3

195

1033

G82.4

ICD-10 Finland

Spastic tetraplegia

40.3

16.3

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.7

16.3

322

H02AB07

ATC

prednisone; oral

1.7

16.3

362

2305

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

4.2

16.3

104

M41.5

ICD-10 Finland

Other secondary scoliosis

15.4

16.2

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.4

16.2

174

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

16.1

102

418

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

4.8

16.1

WX320

NOMESCO Finland

Spinalanesthesy

1.5

16.1

667

4885

R50.9

ICD-10 Finland

Fever, unspecified

1.6

16.1

396

2587

Z2446

NOMESCO Finland

Social worker

2.0

16.1

168

849

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.8

16.1

302

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.4

16.1

115

499

S14.1

ICD-10 Finland

Other and unspecified injuries of cervical spinal cord

47.8

16.0

R03AC02

ATC

salbutamol; inhalant

1.4

16.0

1411

11817

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.6

16.0

146

J01FA09

ATC

clarithromycin; systemic

1.4

16.0

788

5966

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.1

16.0

221

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

16.0

586

4188

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

16.0

200

1077

C10AC01

ATC

colestyramine; oral

2.7

15.9

309

C10AA05

ATC

atorvastatin; oral

1.4

15.9

1162

9428

WW502

NOMESCO Finland

Autotransfusion

5.4

15.9

A10AE06

ATC

insulin degludec; parenteral

2.4

15.9

108

458

N32.83

ICD-10 Finland

Nozzle synergy in the bladder neck

12.3

15.8

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

15.8

823

6293

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

15.8

302

1849

R27.0

ICD-10 Finland

Ataxia, unspecified

6.9

15.7

G91.0

ICD-10 Finland

Communicating hydrocephalus

+∞

15.6

G992, D321,

ICD-10 Finland

+∞

15.6

UDC00

NOMESCO Finland

Ear microscopy

1.9

15.6

204

1114

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

15.6

1446

12193

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

15.6

279

1677

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

15.5

718

5367

ZXA10

NOMESCO Finland

Bilateral

1.6

15.5

467

3197

ABD40

NOMESCO Finland

Implantation of spinal injection device

160.9

15.5

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

160.9

15.5

R03BA05

ATC

fluticasone; inhalant

1.6

15.4

452

3076

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.9

15.4

113

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.0

15.4

221

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

15.3

1879

16565

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.0

15.3

183

969

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

15.3

502

3499

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.7

15.3

127

SPAT1097

SPAT

Recording of ECG

1.6

15.3

380

2488

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

15.2

121

549

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

3.4

15.2

161

PA6AD

NOMESCO Finland

CT of neck arteries

2.5

15.2

376

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.5

15.2

382

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

15.1

347

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

15.1

157

792

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

15.1

160

813

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

15.1

1117

9062

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

15.0

336

2142

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

15.0

654

4829

H02AB09

ATC

hydrocortisone; systemic

2.8

15.0

257

K02.1

ICD-10 Finland

Caries of dentine

1.4

15.0

1508

12850

A02BC04

ATC

rabeprazole; oral

1.8

14.9

239

1391

E87.6

ICD-10 Finland

Hypokalaemia

2.3

14.9

109

478

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

14.9

166

859

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.7

14.8

259

1546

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

5.0

14.8

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

14.8

365

2385

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.9

14.7

232

A01AB09

ATC

miconazole; local oral

1.8

14.7

217

1231

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.9

14.7

207

1158

D43.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Spinal cord

25.2

14.7

R06AE07

ATC

cetirizine; oral

1.4

14.7

1075

8694

A02BA02

ATC

ranitidine; systemic

1.5

14.6

490

3431

M01AH03

ATC

valdecoxib; oral

2.0

14.6

166

865

N02AJ13

ATC

tramadol and paracetamol; systemic

2.7

14.6

289

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

14.5

138

673

D12

ICPC

Constipation

2.3

14.5

111

496

J01CF05

ATC

flucloxacillin; systemic

1.9

14.5

201

1119

ABC04

NOMESCO Finland

Percutaneous endoscopic discectomy for thoracic intervertebral disc displacement

150.8

14.5

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.9

14.4

194

1069

L09

ICPC

Arm symptom/complaint

2.1

14.4

135

655

S29

ICPC

Skin symptom/complaint other

1.5

14.4

545

3910

C10AA01

ATC

simvastatin; oral

1.4

14.3

1089

8848

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

14.3

329

2112

G82.0

ICD-10 Finland

Flaccid paraplegia

27.3

14.3

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

27.3

14.3

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

14.2

349

2275

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

14.2

276

A10BH01

ATC

sitagliptin; oral

1.7

14.2

270

1649

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

14.1

230

1344

E66.8

ICD-10 Finland

Other obesity

2.0

14.1

150

763

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.6

14.1

312

1982

N07BA03

ATC

varenicline; oral

2.1

14.1

133

647

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

14.1

108

483

G63.2

ICD-10 Finland

Diabetic polyneuropathy

6.4

14.1

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

14.1

274

1683

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

14.0

964

7700

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

14.0

619

4575

M01AX05

ATC

glucosamine; oral

1.5

14.0

504

3579

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

13.9

342

2229

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

13.9

246

1472

N06AX12

ATC

bupropion; oral

2.0

13.9

160

837

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

13.9

346

2263

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

13.9

445

3082

R25.2

ICD-10 Finland

Cramp and spasm

2.7

13.9

285

SFA10

NOMESCO Finland

One-surface restoration

1.4

13.8

1414

12017

H3601, E103,

ICD-10 Finland

4.7

13.8

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.1

13.7

182

R52.0

ICD-10 Finland

Acute pain

2.4

13.7

388

R32

ICD-10 Finland

Unspecified urinary incontinence

2.6

13.7

316

M02AA10

ATC

ketoprofen; topical

1.5

13.6

416

2850

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

13.6

182

1001

D07AC01

ATC

betamethasone; topical

1.4

13.6

952

7619

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.9

13.6

210

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.8

13.6

243

G992, C795,

ICD-10 Finland

+∞

13.5

ABC13

NOMESCO Finland

Microsurgical excision of thoracic intervertebral disc displacement

+∞

13.5

EBA00

NOMESCO Finland

Extraction of tooth

1.4

13.5

927

7389

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

13.5

756

5826

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

13.5

180

990

NH1AD

NOMESCO Finland

Ankle and foot CT

2.6

13.3

285

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.4

13.3

363

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

13.3

361

2409

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

13.3

257

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

13.3

305

1955

9201

FHL

Anterior decompression surgery (also includes dees)

11.5

13.3

SPAT1104

SPAT

Monitoring of emergency patient

1.9

13.3

174

951

J01AA02

ATC

doxycycline; systemic

1.4

13.3

2091

18950

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

13.2

451

3164

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.0

13.2

138

698

M01AX01

ATC

nabumetone; oral

2.1

13.1

117

557

N05CF02

ATC

zolpidem; oral

1.5

13.1

440

3074

JF1AD

NOMESCO Finland

Small bowel CT

4.3

13.1

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.9

13.1

178

984

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

12.2

13.1

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

4.8

13.1

C07AB02

ATC

metoprolol; systemic

1.5

13.0

492

3521

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

13.0

260

1607

C08CA02

ATC

felodipine; oral

1.7

13.0

247

1506

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

13.0

226

SPAT1240

SPAT

Therapeutic discussion

1.7

13.0

223

1324

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

12.9

196

1121

F34.1

ICD-10 Finland

Dysthymia

2.3

12.9

424

J37.0

ICD-10 Finland

Chronic laryngitis

2.3

12.9

100

450

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.4

12.9

138

J45.8

ICD-10 Finland

Mixed asthma

2.4

12.7

358

U05

ICPC

Urination problems other

1.9

12.7

154

820

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.5

12.7

322

M75.8

ICD-10 Finland

Other shoulder lesions

2.2

12.6

110

519

M46.4

ICD-10 Finland

Discitis, unspecified

5.5

12.6

R01AD09

ATC

mometasone; nasal

1.3

12.6

1115

9226

M77.1

ICD-10 Finland

Lateral epicondylitis

1.8

12.5

201

1169

ZXE00

NOMESCO Finland

One hour or less

1.4

12.5

944

7622

A10BJ02

ATC

liraglutide; parenteral

2.4

12.5

374

G90.2

ICD-10 Finland

Horner syndrome

130.6

12.4

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

5.6

12.4

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

5.0

12.4

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

12.4

197

1144

M51

ICD-10 Finland

Other intervertebral disc disorders

4.6

12.4

EB1VA, ,

NOMESCO Finland

1.5

12.3

464

3316

ZXA05

NOMESCO Finland

Left side

1.4

12.3

615

4634

N01

ICPC

Headache

1.7

12.3

238

1459

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

12.3

734

5703

A03FA02

ATC

cisapride; oral, rectal

1.8

12.2

183

1043

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.2

12.2

454

AB3CB

NOMESCO Finland

Lumbar myelography

37.7

12.2

J01FA10

ATC

azithromycin; systemic

1.3

12.2

1408

12092

J01MA01

ATC

ofloxacin; systemic

1.7

12.2

215

1286

SPAT1325

SPAT

Vaccination

1.4

12.2

804

6350

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

12.2

103

481

M01AB01

ATC

indometacin; systemic, rectal

1.8

12.2

203

1195

M40.1

ICD-10 Finland

Other secondary kyphosis

15.9

12.1

TKC20, ,

SPAT

4.6

12.1

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.8

12.0

179

1019

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

5.3

12.0

FN1AD

NOMESCO Finland

CT of coronary arteries

2.7

12.0

225

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.6

12.0

110

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.5

12.0

289

J01FA06

ATC

roxithromycin; oral

1.3

12.0

994

8129

R03BB04

ATC

tiotropium bromide; inhalant

1.6

11.9

270

1724

SFA20

NOMESCO Finland

Two-surface restoration

1.3

11.9

1496

12984

M04AA01

ATC

allopurinol; systemic

1.5

11.9

346

2343

WX722

NOMESCO Finland

PEEP

2.0

11.9

132

683

G04BD11

ATC

fesoterodine; oral

2.4

11.8

333

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.3

11.8

383

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

3.7

11.8

N18.8

ICD-10 Finland

Other chronic renal failure

2.5

11.8

279

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

11.8

166

928

U02

ICPC

Urinary frequency/urgency

1.5

11.8

361

2471

SPAT1151

SPAT

Treatment of major wounds

3.4

11.8

121

J04AB02

ATC

rifampicin; systemic

3.3

11.8

131

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.2

11.7

436

A07AA02

ATC

nystatin; oral

1.9

11.7

147

793

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

11.7

246

1542

WGA11

NOMESCO Finland

Planning of pain management

4.9

11.7

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.8

11.7

206

L04AA13

ATC

[U] leflunomide

2.5

11.6

293

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

11.6

697

5415

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.4

11.5

325

Z71.8

ICD-10 Finland

Other specified counselling

1.4

11.5

827

6607

G04CA01

ATC

alfuzosin; oral

1.5

11.5

344

2343

G95.1

ICD-10 Finland

Vascular myelopathies

+∞

11.5

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

11.4

125

643

TK800

NOMESCO Finland

Hemodialysis

2.6

11.4

254

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

3.1

11.4

154

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.1

11.4

111

547

A02BB01

ATC

misoprostol; oral

4.8

11.4

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.7

11.4

231

R68.2

ICD-10 Finland

Dry mouth, unspecified

4.7

11.4

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

4.7

11.4

KED33

NOMESCO Finland

Transurethral incision of prostate

3.1

11.4

149

L15

ICPC

Knee symptom/complaint

1.4

11.4

658

5076

J01MA14

ATC

moxifloxacin; systemic

1.7

11.3

235

1467

SPAT1050

SPAT

Extensive neurological examination

2.8

11.3

198

XA800

NOMESCO Finland

Neuropsychological investigation

2.1

11.3

106

515

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

11.3

2419

22675

A10BB01

ATC

glibenclamide; oral

2.2

11.3

410

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.8

11.3

M65.3

ICD-10 Finland

Trigger finger

1.9

11.3

136

724

R01AD08

ATC

fluticasone; nasal

1.4

11.3

687

5345

A10BH05

ATC

linagliptin; oral

1.9

11.3

135

717

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.0

11.2

124

640

Z2445

NOMESCO Finland

Psychologist

2.3

11.2

379

L16

ICPC

Ankle symptom/complaint

1.6

11.2

303

2017

NAW10

NOMESCO Finland

Reoperation for superficial infection in in surgery of spine or neck

17.1

11.2

NH2AA

NOMESCO Finland

Heel X-ray examination

4.6

11.2

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

5.6

11.2

N06AB03

ATC

fluoxetine; oral

1.6

11.2

293

1938

A06AC51

ATC

ispaghula, combinations; oral

2.0

11.1

122

628

7211A

ICD-9 Finland

Spondylosis and allied disorders, Cervical spondylosis with myelopathy

25.1

11.1

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

11.1

124

643

A11CC03

ATC

alfacalcidol; systemic

2.5

11.1

294

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

11.0

108

534

NK4EA

NOMESCO Finland

Joint X-ray examintion with load or wrench not elsewhere classified

3.8

11.0

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

4.3

11.0

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

11.0

147

809

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.5

11.0

265

R31

ICD-10 Finland

Unspecified haematuria

1.6

11.0

269

1750

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.2

11.0

137

318

Kela drug reimbursment

Teriparatide

4.8

11.0

R20.0

ICD-10 Finland

Anaesthesia of skin

4.5

10.9

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

3.0

10.9

153

N05BA12

ATC

alprazolam; oral

1.6

10.9

246

1569

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

10.9

675

5262

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.7

10.9

214

R41.0

ICD-10 Finland

Disorientation, unspecified

2.3

10.9

334

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.5

10.8

261

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

4.2

10.8

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

10.8

418

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

10.8

204

1243

A02BA04

ATC

nizatidine; systemic

1.7

10.8

184

1090

NA7AD

NOMESCO Finland

Spine CT

10.6

10.8

H03AA01

ATC

levothyroxine sodium; systemic

1.4

10.7

548

4135

H05AA02

ATC

teriparatide; parenteral

4.9

10.7

AA1AA

NOMESCO Finland

Head X-ray examination

4.7

10.7

XQ800

NOMESCO Finland

Prick test

1.8

10.7

170

987

L04AA01

ATC

[U] ciclosporin

3.3

10.7

124

ZZA00

NOMESCO Finland

Split skin graft

2.3

10.6

337

WX872

NOMESCO Finland

Intensive care

1.9

10.6

140

768

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

10.5

580

4431

A11

ICPC

Chest pain NOS

1.6

10.5

229

1447

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

10.5

201

1228

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.1

10.5

469

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

10.5

476

R26.0

ICD-10 Finland

Ataxic gait

10.1

10.5

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

9.2

10.5

M01AC01

ATC

piroxicam; systemic, rectal

1.5

10.5

338

2337

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

10.5

555

4212

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

10.5

121

635

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

10.5

140

771

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

4.6

10.5

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.6

10.4

242

ABC33

NOMESCO Finland

Decompression of thoracic nerve roots

110.4

10.4

J01DA09

ATC

[U] cefadroxil

1.4

10.4

624

4833

U28

ICPC

Limited function/disability (U)

3.4

10.4

106

M03BB53

ATC

chlorzoxazone, combinations excl. psycholeptics; oral

3.2

10.4

126

N06AB06

ATC

sertraline; oral

1.6

10.4

250

1619

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.4

10.4

303

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.3

10.4

322

M89.0

ICD-10 Finland

Algoneurodystrophy

4.2

10.3

JN4AD

NOMESCO Finland

Body CT examination

1.5

10.3

317

2169

T91.1

ICD-10 Finland

Sequelae of fracture of spine

12.1

10.3

S70.0

ICD-10 Finland

Contusion of hip

2.0

10.3

104

520

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

32.6

10.3

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

10.3

407

ZA1.0

ICD-10 Finland

Shoulder region

2.4

10.3

305

U13

ICPC

Bladder symptom/complaint other

2.3

10.2

356

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

10.2

142

792

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

10.2

215

1348

D11

ICPC

Diarrhoea

1.6

10.2

268

1772

K07

ICPC

Swollen ankles/oedema

1.9

10.2

129

698

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

10.2

162

941

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.2

10.2

363

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

10.1

173

1025

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

10.1

160

927

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.2

10.1

396

N06AX17

ATC

milnacipran; oral

3.4

10.1

103

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

10.1

1689

15078

XF402

NOMESCO Finland

ECG with work load test

1.6

10.1

267

1767

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.2

10.1

358

QDB10, ,

SPAT

2.2

10.1

371

TQW40, ,

SPAT

1.5

10.1

279

1867

PD5AD

NOMESCO Finland

CT of aorta

2.3

10.1

314

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

10.0

115

602

R20.1

ICD-10 Finland

Hypoaesthesia of skin

4.8

10.0

S01.0

ICD-10 Finland

Open wound of scalp

1.7

10.0

203

1261

WX720

NOMESCO Finland

Own respiration

1.9

10.0

129

703

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.8

10.0

157

909

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

10.0

130

711

R03BA08

ATC

ciclesonide; inhalant

1.6

10.0

212

1333

H02.4

ICD-10 Finland

Ptosis of eyelid

2.2

9.9

393

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

9.9

138

770

C08CA13

ATC

lercanidipine; oral

1.5

9.9

375

2677

NB1AD

NOMESCO Finland

Shoulder CT examination

2.6

9.9

213

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.1

9.9

427

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.5

9.9

243

A29

ICPC

General symptom/complaint other

1.5

9.9

339

2375

N06AX03

ATC

mianserin; oral

1.9

9.8

121

649

NAG99

NOMESCO Finland

Other excision, reconstruction or fusion of joints of spine, unspecified

20.1

9.8

7227A

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[KAULANIKAMAN VÄLILEVYTYRÄ JUURIOIREINEEN]

9.6

9.7

B01AB10

ATC

tinzaparin; parenteral

1.5

9.7

283

1914

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

9.7

567

4367

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.8

9.7

175

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

9.7

108

560

K30

ICD-10 Finland

Functional dyspepsia

1.5

9.7

277

1866

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

2.5

9.7

251

D07AD01

ATC

clobetasol; topical

1.4

9.7

416

3040

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

2.5

9.7

239

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

9.7

265

1768

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

9.7

546

4183

C09AA05

ATC

ramipril; oral

1.4

9.7

624

4883

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.9

9.6

159

SPAT1284

SPAT

Extensive health certificate

2.4

9.6

264

N17

ICPC

Vertigo/dizziness

1.5

9.6

308

2126

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

9.6

113

597

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

9.6

300

2060

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.0

9.6

486

G72.9

ICD-10 Finland

Myopathy, unspecified

3.7

9.6

C01CA24

ATC

epinephrine; parenteral

1.8

9.6

140

793

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.3

9.6

SFA30

NOMESCO Finland

Three-surface restoration

1.3

9.6

1100

9334

K07.61

ICD-10 Finland

Cracking jaw joint

2.7

9.5

188

J01DC02

ATC

cefuroxime; systemic

1.8

9.5

130

721

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

9.5

126

692

L04AX03

ATC

methotrexate; systemic

1.6

9.5

247

1628

T91.8

ICD-10 Finland

Sequelae of other specified injuries of neck and trunk

15.1

9.5

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

9.5

502

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.0

9.5

139

ZY010

NOMESCO Finland

Hospital outpatient

1.9

9.4

115

615

U01

ICPC

Dysuria/painful urination

1.7

9.4

176

1069

XG466

NOMESCO Finland

Sleep oxymetry

2.1

9.4

408

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

3.7

9.4

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

9.4

362

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.6

9.4

201

NA1BD

NOMESCO Finland

Extensive cervical spine CT examination

30.1

9.4

H53.2

ICD-10 Finland

Diplopia

2.1

9.4

402

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

+∞

9.4

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

+∞

9.4

G93.0

ICD-10 Finland

Cerebral cysts

+∞

9.4

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

+∞

9.4

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

9.3

584

4545

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.5

9.3

NGQ20

NOMESCO Finland

Amputation of lower leg

4.4

9.3

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

6.9

9.3

OAB36

NOMESCO Finland

Guidance and counselling related to exercise

4.5

9.3

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

9.3

306

2124

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

9.3

368

2649

NA2DG

NOMESCO Finland

Thoracal spine very extensive MRI examination with high intensity magnet

8.7

9.3

C09AA02

ATC

enalapril; systemic

1.4

9.3

471

3545

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.3

9.2

307

R03DC03

ATC

montelukast; oral

1.4

9.2

382

2772

H81.3

ICD-10 Finland

Other peripheral vertigo

2.3

9.2

320

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.7

9.2

177

1084

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

9.2

182

1123

J01MA06

ATC

norfloxacin; oral

1.5

9.2

296

2045

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.9

9.2

109

578

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.9

9.2

107

564

A10BJ06

ATC

semaglutide; parenteral

1.7

9.2

150

879

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

3.3

9.2

100

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.0

9.2

131

S76

ICPC

Skin infection other

1.8

9.2

141

812

J01XX08

ATC

linezolid; systemic

3.9

9.1

N32.0

ICD-10 Finland

Bladder-neck obstruction

3.9

9.1

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.5

9.1

234

R5140, ,

SPAT

2.8

9.1

153

SPAT1234

SPAT

Support of social functional capacity

1.9

9.1

120

659

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.5

9.1

290

2000

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.6

9.1

204

1300

A07AA09

ATC

vancomycin; oral

2.8

9.1

159

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.0

9.0

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

9.0

725

5851

C03DA01

ATC

spironolactone; oral

1.5

9.0

301

2095

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

10.1

9.0

L85

ICPC

Acquired deformity of spine

7.0

9.0

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.0

9.0

127

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044640) Blood type and Crossmatch panel - Blood

1492

8275

2.71

144.65

3.2

2.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1850

11807

2.65

128.67

3.8

2.8

—

estimate

—

(3032080) INR in Blood by Coagulation assay

1861

11979

2.63

125.98

13.7

15.2

1.16

1.26

inr

17.10

1585

9909

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1373

7703

2.53

124.18

2.7

2.2

223.52

252.25

u/l

0.47

1311

7263

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1922

13024

2.50

109.04

9.7

7.7

1.21

mmol/l

1.13

1634

11287

(3013826) Glucose [Moles/volume] in Serum or Plasma

2102

15014

2.58

103.53

7.4

5.2

6.96

6.77

mmol/l

3.06

2054

14297

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1130

6311

2.32

96.81

3.1

2.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1737

11689

2.27

93.37

8.8

6.9

1.20

1.21

mmol/l

1.70

1594

10824

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1507

9730

2.18

87.69

5.0

3.7

105.50

63.34

ng/l

0.41

1187

7004

(3026008) Bacteria identified in Urine by Culture

1221

7397

2.15

82.07

4.9

3.2

—

(3023368) Bacteria identified in Blood by Culture

1190

7342

2.08

74.16

6.3

4.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1289

8218

2.05

73.12

3.5

2.7

109.08

61.20

u/l

0.40

1205

7600

(3024561) Albumin [Mass/volume] in Serum or Plasma

1654

11728

1.99

67.34

6.3

5.2

34.97

35.57

g/l

3.69

1549

11014

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2302

18475

2.35

66.75

6.3

4.4

14.27

12.38

mm/h

5.98

2171

17268

(3031040) Bacteria [#/volume] in Urine by Automated count

2082

16087

2.13

65.94

7.2

4.6

328.57

1422.26

e6/l

1.81

227

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1626

11534

1.97

65.26

2.6

2.1

96.08

95.65

pmol/l

0.13

925

6092

(3042936) Bacteria identified in Isolate by Culture

703

3789

2.14

60.51

3.0

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

780

4397

2.07

59.45

2.2

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1151

7470

1.91

58.12

2.0

1.7

19.60

20.40

nmol/l

1.00

975

6277

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1218

8053

1.90

58.09

3.3

3.2

1110.63

1308.56

ng/l

1.29

1044

6922

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1819

13742

1.91

56.64

7.1

7.0

10.35

11.72

umol/l

2.83

1738

13142

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2356

19617

2.23

54.01

10.8

8.6

81.45

79.94

u/l

0.49

2254

18674

(3012095) Magnesium [Moles/volume] in Serum or Plasma

771

4472

2.00

53.38

3.6

3.5

0.81

0.82

mmol/l

0.23

725

4232

(3036481) Cortisol [Moles/volume] in Serum or Plasma

484

2360

2.27

52.77

2.3

2.2

352.43

378.63

nmol/l

2.29

446

2191

(3003396) Base excess in Arterial blood by calculation

592

3132

2.13

52.60

7.3

8.3

1.11

0.98

mmol/l

0.37

512

2600

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

894

5504

1.91

51.62

2.0

1.7

1.08

1.29

mg/l

1.73

681

4326

(3019309) Folate [Moles/volume] in Red Blood Cells

734

4238

1.99

51.16

2.0

1.7

1101.01

1171.58

nmol/l

1.23

559

3194

(3037522) Nuclear Ab [Titer] in Serum

635

3487

2.06

50.90

1.4

407.08

495.10

titre

0.70

130

771

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

590

3156

2.10

50.73

7.5

8.4

5.23

5.12

kpa

2.08

574

3038

(3027801) Oxygen [Partial pressure] in Arterial blood

590

3156

2.10

50.73

7.4

8.4

13.26

12.24

kpa

4.17

573

3040

(3022096) Basophils/Leukocytes in Blood

1610

11950

1.81

50.20

8.3

6.8

0.67

0.69

0.53

1523

11202

(3019069) Monocytes/Leukocytes in Blood

1612

11974

1.81

50.08

8.3

6.8

8.89

8.96

0.45

1526

11235

(3019225) pH of Specimen

500

2522

2.19

49.95

4.9

4.4

7.37

7.36

0.79

364

1823

(3019977) pH of Arterial blood

586

3151

2.09

49.57

7.5

8.4

7.41

7.42

1.10

332

1711

(3006504) Eosinophils/Leukocytes in Blood

1606

11949

1.80

49.28

8.2

6.7

2.91

2.85

0.44

1524

11206

(3002030) Lymphocytes/Leukocytes in Blood

1634

12222

1.80

49.23

8.2

6.7

26.21

27.32

3.92

1562

11591

(3022948) Iron [Moles/volume] in Serum or Plasma

756

4469

1.95

48.86

3.3

2.7

11.80

13.12

umol/l

5.42

693

4180

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1029

6733

1.83

48.35

2.7

2.3

2.89

2.85

mg/l

0.18

891

5810

(3007853) Bacteria identified in Skin by Aerobe culture

560

2999

2.08

47.70

2.5

1.8

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

385

1773

2.36

47.68

4.6

3.8

5.24

5.15

kpa

1.26

371

1708

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1545

11436

1.78

47.53

3.0

2.4

77.83

77.96

nmol/l

0.06

1403

10339

(3019198) Lymphocytes [#/volume] in Blood

1723

13238

1.78

45.87

7.8

6.5

1.87

1.91

e9/l

0.37

1582

11574

(3003458) Phosphate [Moles/volume] in Serum or Plasma

628

3556

1.99

45.60

8.4

6.3

1.06

1.03

mmol/l

1.39

599

3316

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1520

11282

1.75

45.51

3.9

3.1

136.51

142.10

ug/l

0.43

1393

10532

(3006315) Basophils [#/volume] in Blood

1698

13007

1.77

45.51

7.8

6.4

0.04

e9/l

0.91

1532

11083

(3013115) Eosinophils [#/volume] in Blood

1739

13414

1.78

45.48

7.9

6.6

0.20

0.19

e9/l

1.96

1578

11615

(3018010) Neutrophils/Leukocytes in Blood

1592

11976

1.76

45.43

8.0

6.6

58.29

57.57

1.71

1531

11456

(3001604) Monocytes [#/volume] in Blood

1694

12971

1.77

45.43

7.8

6.4

0.62

0.59

e9/l

3.77

1527

11058

(3009343) pH of Capillary blood

371

1718

2.34

45.24

4.7

3.8

7.41

7.42

1.17

307

1429

(3009261) Glucose [Presence] in Urine by Test strip

1732

13367

1.77

44.97

5.3

3.9

0.01

0.13

estimate

0.51

374

2626

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

839

5257

1.85

44.63

2.0

1.7

18513558.91

37569364.31

pmol/l

0.64

686

4352

(3016502) Oxygen saturation in Arterial blood

526

2818

2.07

44.46

7.5

8.7

96.11

95.54

1.82

511

2723

(3004789) Transferrin [Mass/volume] in Serum or Plasma

703

4187

1.90

43.70

3.3

2.7

2.28

2.30

g/l

0.53

644

3868

(3035350) Ketones [Presence] in Urine by Test strip

1717

13278

1.75

43.64

5.3

3.9

3.97

5.90

estimate

0.18

414

2821

(3015736) pH of Urine

1432

10538

1.73

43.41

4.3

3.4

6.20

6.21

0.07

824

5894

(3021601) Nitrite [Presence] in Urine by Test strip

1700

13135

1.74

43.09

5.3

3.9

0.00

estimate

0.50

399

2760

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

173

555

3.26

43.02

1.7

1.2

607.84

595.10

mg/l

0.07

165

524

(3026782) Osmolality of Urine

797

4965

1.84

42.90

3.9

2.9

520.57

535.36

mosm/kgh2o

1.21

736

4333

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2026

16481

1.82

42.75

4.6

3.4

58.31

52.90

u/l

1.04

1904

15413

(3007930) Methemoglobin/Hemoglobin.total in Blood

264

1078

2.60

42.21

5.9

5.1

0.93

0.88

0.90

257

1011

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

340

1567

2.33

41.76

8.7

11.1

16.16

16.04

0.35

333

1507

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2231

18759

1.91

41.57

5.3

4.3

14.96

14.83

pmol/l

1.50

2050

17211

(3002173) Hemoglobin [Mass/volume] in Arterial blood

492

2643

2.04

41.00

8.2

9.2

121.12

121.99

g/l

0.41

486

2577

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

247

994

2.63

40.65

2.3

308.03

508.67

ug/l

1.35

231

949

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

384

1884

2.20

40.53

1.9

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

654

3897

1.88

40.14

3.4

2.7

21.34

23.02

2.28

597

3633

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

274

1175

2.48

39.46

5.7

4.9

1.73

1.61

1.22

266

1107

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

349

1675

2.24

38.80

2.7

2.4

17.27

20.16

au/ml

0.26

150

(3000850) Epithelial cells [#/volume] in Urine

880

5809

1.75

38.12

3.5

2.7

5.24

5.29

e6/l

0.04

832

5289

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2530

22426

2.26

38.06

6.7

5.2

1.88

1.94

mu/l

1.64

2349

20661

(3022313) Gas panel - Capillary blood

276

1217

2.41

37.33

5.1

3.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

324

1536

2.25

37.04

1.5

1.3

95.19

57.54

au/ml

1.09

110

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

490

2722

1.97

36.81

5.0

3.5

—

(3044290) Cell count panel - Cerebral spinal fluid

143

450

3.29

36.66

1.8

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

731

4621

1.79

36.53

1.4

1.3

33.57

33.61

iu/ml

0.00

205

1437

(3033658) Prothrombin time (PT) actual/Normal

954

6530

1.70

35.74

5.1

4.2

91.18

88.92

2.14

927

6396

(3018677) aPTT in Platelet poor plasma by Coagulation assay

612

3702

1.83

35.23

2.6

2.1

29.24

29.71

1.08

587

3596

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

558

3286

1.87

34.97

2.1

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

546

3206

1.87

34.49

5.4

5.1

32.21

32.32

0.08

389

2069

(3020682) Albumin/Creatinine [Ratio] in Urine

1242

9160

1.64

34.48

5.2

4.2

14.19

8.59

mg/mmol

2.64

836

5684

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

815

5397

1.72

34.20

1.4

1.3

1.71

1.52

u/ml

0.13

196

1421

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

310

1497

2.20

33.76

4.7

3.6

1.93

1.89

mmol/l

0.07

242

1112

(3026493) Urate [Moles/volume] in Serum or Plasma

996

6990

1.66

33.38

3.3

2.8

343.44

347.75

umol/l

0.66

875

6190

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

150

516

3.01

33.09

1.7

1.1

3.85

3.80

mmol/l

0.15

141

490

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

141

468

3.12

33.08

1.8

1.2

15.71

37.83

e6/l

0.57

101

336

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2637

24034

2.53

33.00

29.0

16.5

23.26

25.17

mg/l

2.55

2381

19851

(3009508) Creatinine [Moles/volume] in Urine

1254

9343

1.62

32.91

4.2

3.5

7.28

7.61

mmol/l

1.99

1039

7872

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

141

476

3.07

32.14

1.9

1.2

394.42

1412.59

e6/l

0.89

115

367

(3005719) IgG [Mass/volume] in Serum or Plasma

376

1992

2.02

32.02

3.0

9.86

10.75

g/l

3.31

336

1837

(3012516) Albumin [Mass/volume] in Urine

1213

9012

1.61

31.89

4.2

3.5

81.48

47.25

mg/l

3.00

819

5730

(3008152) Bicarbonate [Moles/volume] in Arterial blood

322

1615

2.12

31.77

7.4

6.8

25.18

24.55

mmol/l

2.83

315

1540

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

674

4312

1.74

31.64

1.4

1.3

21.10

12.13

u/ml

0.39

227

1640

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

229

1001

2.40

31.46

2.0

—

(3045424) Erythrocytes [Presence] in Urine

271

1274

2.25

31.44

2.5

2.2

6.41

0.01

estimate

0.49

392

(3047181) Lactate [Moles/volume] in Blood

190

762

2.60

31.35

6.4

5.7

1.18

1.38

mmol/l

2.01

172

665

(3020630) Protein [Mass/volume] in Serum or Plasma

420

2330

1.94

31.30

2.8

65.75

66.50

g/l

1.13

390

2147

(3029937) Albumin [Presence] in Urine by Test strip

1025

7347

1.62

31.01

5.3

4.0

0.01

0.00

estimate

0.18

373

2543

(3013650) Neutrophils [#/volume] in Blood by Automated count

1788

14623

1.61

30.92

10.7

10.0

4.34

4.13

e9/l

3.12

1626

12653

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

161

4.63

30.86

1.3

1.1

43.42

41.21

mg/l

0.16

133

(3039000) Anion gap in Blood by calculation

147

527

2.89

30.11

6.9

6.7

10.42

11.46

mmol/l

3.39

139

465

(3018572) Chloride [Moles/volume] in Blood

147

527

2.89

30.11

6.8

6.7

105.24

105.18

mmol/l

0.06

139

465

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1162

8652

1.58

29.58

3.5

3.3

33.59

38.57

u/l

1.02

1085

8155

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

159

4.56

29.46

1.2

1.1

345.28

298.07

mg/l

0.38

135

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

195

4.14

28.94

1.8

1.3

—

(3045414) Leukocytes [Presence] in Urine

427

2449

1.88

28.59

2.5

2.2

0.00

0.01

estimate

0.78

506

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

180

4.25

28.51

1.6

1.2

2.15

2.30

mmol/l

0.40

168

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

335

1784

2.00

27.93

7.9

9.1

24.97

24.95

mmol/l

0.04

330

1777

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

244

1157

2.21

27.64

2.0

1.9

3.26

1.83

ug/l

0.42

221

1036

(3020779) Urea [Moles/volume] in Serum or Plasma

431

2507

1.85

27.53

9.8

7.7

10.16

10.11

mmol/l

0.04

415

2416

(3002582) Erythrocytes [#/volume] in Urine

1126

8458

1.55

26.80

4.8

3.4

179.86

93.05

e6/l

0.37

968

6457

(3004588) Protein electrophoresis panel - Serum or Plasma

348

1910

1.94

26.53

2.8

2.6

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

120

4.91

26.48

1.4

1.2

0.50

0.53

ratio

0.62

(3019550) Sodium [Moles/volume] in Serum or Plasma

2684

24977

2.59

26.44

32.9

19.5

139.49

139.73

mmol/l

5.15

2655

24501

(3000494) Fungus identified in Specimen by Culture

518

3218

1.75

26.44

1.8

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

251

3.59

26.31

2.0

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

204

917

2.32

26.23

1.9

1.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

359

1998

1.91

26.23

5.4

4.1

94.76

90.74

ng/l

0.34

312

1736

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

154

4.36

26.03

1.2

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

113

380

3.06

25.94

8.0

6.2

11.37

11.76

mg/l

0.47

106

361

(3007164) IgA [Mass/volume] in Serum or Plasma

708

4801

1.63

25.91

1.7

1.5

2.45

2.55

g/l

0.61

432

2954

(3030467) Casts [#/volume] in Urine by Automated count

994

7308

1.56

25.78

4.6

3.3

0.47

0.43

e6/l

0.18

843

5350

(3041096) Erythrocytes [Presence] in Urine by Automated

957

6985

1.56

25.59

5.0

3.4

0.79

0.15

estimate

0.38

326

2157

(3023103) Potassium [Moles/volume] in Serum or Plasma

2683

25031

2.52

25.06

33.2

19.7

4.01

3.98

mmol/l

5.00

2654

24512

(3009445) Proteinase 3 Ab [Units/volume] in Serum

232

1121

2.17

25.03

1.3

1.6

11.36

20.55

iu/ml

—

(3018095) Leukocytes [#/volume] in Urine

1233

9555

1.52

24.81

5.6

4.0

142.75

96.48

e6/l

0.48

1012

6773

(3018418) pH of Serum or Plasma

1046

7828

1.53

24.78

6.0

4.4

7.40

0.67

798

5596

(3048689) Calprotectin [Mass/mass] in Stool

482

2990

1.74

24.57

2.2

2.5

192.13

142.96

ug/g

1.37

376

2441

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

202

935

2.25

24.22

5.6

3.8

25.11

24.83

mmol/l

0.65

191

867

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

308

1672

1.95

24.16

7.9

10.8

24.58

24.35

mmol/l

0.65

301

1646

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

201

938

2.23

23.62

1.2

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1262

9907

1.50

23.40

5.4

3.8

0.40

0.07

estimate

0.53

338

2271

(3024869) Neuronal Ab [Presence] in Serum

8.03

23.02

1.1

—

(3017732) Neutrophils [#/volume] in Blood

510

3285

1.67

22.45

3.2

3.4

4.51

4.56

e9/l

0.04

432

2845

(3012544) pH of Venous blood

442

2744

1.72

22.30

5.7

3.7

7.37

7.38

0.78

291

1572

(40768797) Stomach Pathology biopsy report

556

3669

1.64

22.25

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

142

586

2.50

22.06

1.9

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

497

3195

1.67

22.00

4.1

4.4

238.82

246.13

u/l

0.54

472

3031

(3015377) Calcium [Moles/volume] in Serum or Plasma

1158

9012

1.48

21.97

3.2

3.6

2.34

2.35

mmol/l

2.09

1037

8201

(3023420) DNA double strand Ab [Units/volume] in Serum

212

1043

2.12

21.80

1.6

1.7

3.64

7.10

iu/ml

2.23

235

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2535

23335

1.87

21.65

9.2

6.6

41.26

39.57

mmol/mol

13.72

2377

21813

(3000570) Elastase.pancreatic [Mass/mass] in Stool

172

791

2.25

20.93

1.6

1.4

259.48

275.79

ug/g

0.43

481

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

479

3091

1.66

20.80

2.2

1.8

—

(3023520) Reticulocytes [#/volume] in Blood

399

2453

1.73

20.75

2.7

71.30

70.70

e9/l

0.12

317

1803

(3027945) Reticulocytes/Erythrocytes in Blood

481

3134

1.64

20.05

2.7

1.85

1.82

0.22

429

2808

(3004119) Hemoglobin [Mass/volume] in Venous blood

294

1682

1.84

19.48

4.4

3.0

126.19

129.21

g/l

1.33

279

1636

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

161

747

2.23

19.18

2.3

1.8

—

(3002032) Base excess in Venous blood by calculation

414

2641

1.67

18.65

5.7

3.7

2.00

1.85

mmol/l

0.33

376

2305

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

413

2635

1.66

18.59

2.5

2.3

0.20

0.21

g/l

1.38

387

2468

(3027273) Bicarbonate [Moles/volume] in Venous blood

221

1173

1.96

18.41

4.2

3.3

25.72

25.30

mmol/l

0.82

215

1135

(3015171) Extractable nuclear Ab [Units/volume] in Serum

189

953

2.05

18.18

1.3

1.2

1.51

1.15

u/ml

0.10

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

158

745

2.19

18.09

1.5

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

287

1669

1.80

17.99

2.0

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

419

2708

1.64

17.89

5.8

3.7

5.83

5.82

kpa

0.07

410

2639

(36660697) Celiac disease serology panel - Serum

311

1873

1.74

17.26

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

217

3.19

17.13

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

156

752

2.14

16.90

1.5

1.6

0.24

g/l

0.03

144

718

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

231

1282

1.87

16.81

2.5

2.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

204

1090

1.94

16.66

2.2

1.9

40.14

39.00

u/l

0.34

179

969

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

113

479

2.42

16.61

1.3

120.00

439.50

titre

—

(40761536) Microorganisms panel - Urine sediment

323

1989

1.70

16.52

6.2

4.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2536

23663

1.72

16.41

6.4

5.3

6.25

5.99

mmol/l

12.45

2313

21739

(1616796) Gas panel - Central venous blood

130

592

2.25

16.22

4.0

4.3

—

(3010421) pH of Blood

168

848

2.04

16.12

4.3

4.2

7.41

0.51

163

842

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

158

782

2.08

15.99

1.5

1.6

1.19

g/l

0.00

150

747

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

303

2.76

15.97

2.0

2.3

30.82

19.59

mg/l

0.62

108

(3030981) Hyaline casts [#/volume] in Urine by Automated count

348

2205

1.66

15.96

3.1

2.5

0.26

0.49

e6/l

2.22

336

2121

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

686

5067

1.47

15.83

5.0

3.8

252.85

620.04

ng/l

1.16

543

4069

(3028026) IgM [Mass/volume] in Serum or Plasma

268

1587

1.76

15.75

2.7

2.0

1.59

1.41

g/l

0.28

240

1462

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

329

2062

1.67

15.73

5.5

4.2

1.22

1.23

mmol/l

0.65

282

1784

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

229

3.02

15.67

2.8

2.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

145

702

2.12

15.55

1.8

1.6

12094.11

12068.45

e6/l

0.00

113

479

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

148

726

2.10

15.34

1.3

1.2

1.31

3.52

u/ml

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

148

727

2.09

15.28

1.4

1.3

2.17

5.81

u/ml

1.56

115

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

157

792

2.04

15.10

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

331

2.62

14.96

1.4

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

126

586

2.20

14.96

2.0

2.8

28.95

36.98

umol/l

3.43

120

533

(3014051) Protein [Presence] in Urine by Test strip

895

7013

1.40

14.76

3.9

2.9

0.14

0.01

0.69

168

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2700

25814

2.12

14.35

35.5

21.7

81.66

78.91

umol/l

2.54

2678

25517

(3006653) Thiamine [Moles/volume] in Blood

134

3.55

14.18

1.3

129.94

139.25

nmol/l

0.59

134

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

154

3.35

14.09

1.8

2.5

243.12

210.38

e6/l

0.63

136

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

140

3.47

14.00

1.6

1.9

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

220

1277

1.78

13.82

1.8

1.66

1.54

g/l

1.15

192

1109

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

331

2145

1.62

13.81

2.3

7.59

7.81

ug/l

0.05

281

1912

(3014111) Lactate [Moles/volume] in Serum or Plasma

374

2498

1.57

13.73

8.3

8.4

1.35

1.33

mmol/l

0.13

366

2458

(3000991) Gas panel - Venous blood

360

2387

1.58

13.64

10.6

9.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

124

598

2.12

13.46

5.3

4.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

579

4256

1.45

13.42

4.2

3.1

2.12

2.16

e6/l

0.05

345

2089

(3028626) Oxygen [Partial pressure] in Capillary blood

132

653

2.07

13.40

3.0

3.2

8.06

8.02

kpa

0.12

132

640

(3024354) Oxygen [Partial pressure] in Venous blood

342

2250

1.59

13.38

4.8

3.0

4.79

4.55

kpa

1.32

332

2190

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

4.29

13.37

1.1

1.4

142.04

140.27

nmol/l

0.02

(3003694) ABO and Rh group [Type] in Blood

889

7050

1.38

13.36

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.92

13.24

1.8

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

239

1439

1.72

13.21

3.0

3.4

4.32

4.47

pmol/l

1.53

208

1284

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2514

23632

1.60

13.00

24.8

16.4

79.24

79.54

ml/min/173m2

0.30

2405

21970

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

152

3.26

13.00

1.8

2.4

519.82

573.09

e6/l

0.22

128

(3000330) Specific gravity of Urine by Test strip

215

1266

1.76

12.86

4.5

3.5

1.02

ratio

1.08

202

1152

(3012501) Base excess in Blood by calculation

113

536

2.15

12.81

4.6

5.0

2.50

2.67

mmol/l

0.28

372

(3013290) Carbon dioxide [Partial pressure] in Blood

113

537

2.15

12.75

4.6

5.0

5.18

5.05

kpa

1.00

108

531

(3002179) Metamyelocytes/Leukocytes in Blood

349

2334

1.57

12.70

4.3

4.4

0.86

0.70

0.47

135

725

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2677

25615

1.91

12.68

17.2

12.6

27.18

26.83

u/l

0.35

2603

24889

(3027315) Oxygen [Partial pressure] in Blood

113

539

2.14

12.63

4.6

5.1

8.59

8.43

kpa

0.29

108

532

(3005322) IgE [Units/volume] in Serum or Plasma

257

1597

1.67

12.63

1.4

1.3

325.16

199.33

u/ml

0.52

235

1485

(46235355) HIV 1 and 2 tests - Meaningful Use set

489

3532

1.47

12.32

1.9

1.7

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

297

2.53

12.30

1.8

1.5

55.16

59.02

0.35

183

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

3.77

12.27

1.2

1.1

200.33

504.68

ng/l

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

100

3.74

12.10

3.2

2.8

106.59

148.79

umol/l

0.42

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

220

1329

1.71

12.01

1.5

—

(3021440) Promyelocytes/Leukocytes in Blood

345

2335

1.54

11.88

4.6

0.10

0.12

0.09

116

663

(3017181) Myelocytes/Leukocytes in Blood

357

2436

1.53

11.84

4.6

1.24

0.91

0.71

128

765

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

146

3.19

11.79

1.2

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

170

961

1.82

11.67

3.5

3.9

42.28

58.39

mg/l

1.12

136

819

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

117

3.45

11.66

1.3

1.0

0.99

1.13

u/l

1.09

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

170

962

1.82

11.64

3.5

3.9

28.79

74.75

mg/l

2.06

136

822

(3037756) Immunofixation for Serum or Plasma

117

585

2.04

11.58

1.8

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

609

4634

1.40

11.44

4.1

3.0

1.13

1.03

e6/l

0.41

378

2484

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

149

3.12

11.41

1.2

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.06

11.39

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

422

3008

1.47

11.31

2.8

8.84

8.37

umol/l

0.10

354

2686

(3004809) Band form neutrophils/Leukocytes in Blood

464

2.15

11.20

3.7

3.8

1.43

1.50

0.07

414

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.73

11.12

2.6

2.2

159751.17

32065.86

u/ml

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

195

1166

1.72

11.06

2.8

2.5

4.16

4.21

g/l

0.43

176

1074

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

195

1166

1.72

11.06

2.8

2.5

7.26

7.41

g/l

0.65

176

1073

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

194

1166

1.71

10.80

2.8

2.5

3.44

3.77

g/l

2.10

175

1073

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1590

14042

1.30

10.55

3.1

2.7

—

(4024509) Urine culture

195

1185

1.69

10.43

2.4

2.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

151

853

1.81

10.42

3.4

3.7

5.23

2.80

ratio

0.30

480

(3025159) Blasts/Leukocytes in Blood

339

2349

1.50

10.41

4.7

4.8

0.09

0.23

0.52

116

623

(3037121) Protein [Mass/volume] in Urine

157

899

1.79

10.36

3.9

3.5

557.36

388.85

mg/l

0.68

413

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

118

620

1.94

10.19

1.7

1.6

—

(3017704) Immunofixation for Urine

155

2.93

10.08

1.7

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

119

3.22

9.99

2.7

2.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

290

2.38

9.99

3.3

3.7

61.18

57.87

0.59

249

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

181

1092

1.70

9.95

2.8

2.5

2.67

2.95

g/l

3.89

162

1000

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

151

2.94

9.92

1.4

1.6

5.18

7.67

u/l

1.29

131

(3017143) Hepatitis C virus Ab [Presence] in Serum

364

2584

1.47

9.90

1.8

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

5.16

9.83

1.4

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2441

23055

1.44

9.68

5.2

4.4

1.41

1.31

mmol/l

6.36

2230

21170

(3045716) Anion gap in Serum or Plasma by calculation

277

2.38

9.58

4.0

3.2

10.81

10.62

mmol/l

0.17

272

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

162

958

1.73

9.58

2.9

2.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

107

559

1.95

9.42

1.2

49.54

50.95

u/ml

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

397

2891

1.43

9.42

1.9

1.8

1.68

1.50

3.59

338

2537

(3022145) Colonoscopy Study observation

411

3012

1.43

9.42

1.3

1.4

—

(3044927) Protein electrophoresis panel - Urine

276

2.35

9.20

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

414

3057

1.42

9.08

1.8

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

111

3.18

9.04

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

106

561

1.92

9.00

5.5

483.25

578.49

iu/ml

0.13

(3019150) Specific gravity of Urine by Refractometry

716

5774

1.32

8.96

4.9

4.0

1.02

1.28

kg/l

0.50

521

3852

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

365

2.14

8.85

1.2

1.1

—

4.31

—

(3008898) HLA-B27 [Presence]

133

761

1.78

8.83

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

186

1175

1.62

8.59

1.2

1.1

—

1.39

u/ml

—

(3025941) Bacteria identified in Stool by Culture

200

1286

1.60

8.59

1.3

1.2

—

(3011412) CD3 cells [#/volume] in Blood

235

2.41

8.57

1.9

2.3

1226.98

1163.93

e6/l

0.20

214

(3008757) Leukocyte morphology finding [Identifier] in Blood

260

2.34

8.56

5.1

4.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

138

806

1.75

8.55

3.9

3.0

1.69

1.58

mg/l

0.61

122

733

(3007461) Platelets [#/volume] in Blood

2705

26225

1.80

8.51

41.2

25.2

253.39

248.09

e9/l

4.06

2676

25686

(3035941) MCH [Entitic mass]

2705

26226

1.80

8.50

41.0

25.0

30.42

30.41

0.04

2685

25936

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2705

26227

1.80

8.48

41.1

25.1

91.64

91.37

2.34

2684

25936

(3023410) Appearance of Cerebral spinal fluid

224

2.44

8.48

2.3

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

2705

26229

1.79

8.45

41.2

25.1

4.39

4.49

e12/l

20.95

2670

25603

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2705

26229

1.79

8.45

41.8

25.7

39.70

40.48

11.70

2683

25926

(3010813) Leukocytes [#/volume] in Blood

2705

26230

1.79

8.44

41.3

25.2

7.08

6.73

e9/l

11.22

2670

25607

(3022621) pH of Urine by Test strip

278

1930

1.49

8.43

3.0

2.7

6.13

6.04

0.86

184

1307

(3011985) Renin [Units/volume] in Plasma

359

2.12

8.42

1.5

69.56

81.69

mu/l

0.19

322

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

289

2024

1.48

8.39

3.9

2.8

142.54

194.49

ng/l

2.28

274

1852

(3006184) Hemoglobin [Mass/volume] in Capillary blood

116

648

1.82

8.35

2.7

2.4

124.42

129.46

g/l

1.32

503

(3000963) Hemoglobin [Mass/volume] in Blood

2705

26236

1.79

8.34

41.5

25.3

132.60

135.70

g/l

21.69

2684

25954

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

162

997

1.66

8.30

2.7

2.5

8.94

10.38

g/l

6.53

138

899

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

2.93

8.12

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

164

1021

1.64

8.04

2.7

2.5

0.55

1.14

g/l

1.73

137

875

(3004775) Volume in Urine collected for unspecified duration

206

2.45

7.99

2.5

2.2

604.58

633.31

0.15

132

(3020191) Ethanol [Moles/volume] in Serum or Plasma

194

2.50

7.98

1.3

1.5

1.08

1.21

promille

0.21

152

(40768804) Tissue Pathology biopsy report

1180

10261

1.26

7.94

2.3

2.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2533

24241

1.45

7.88

6.3

5.3

4.47

4.63

mmol/l

12.11

2344

22625

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

224

1508

1.53

7.87

1.2

126.82

155.42

u/ml

0.46

555

(40760892) CBC W Ordered Manual Differential panel - Blood

688

5614

1.30

7.73

5.2

4.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2519

24103

1.43

7.65

6.2

5.2

1.40

1.46

mmol/l

8.35

2320

22362

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

125

734

1.74

7.63

1.3

—

(4015189) Microbial culture of sputum

3.73

7.62

4.4

2.5

—

(3004451) EKG impression Narrative

158

2.62

7.53

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2562

24606

1.46

7.47

7.0

6.0

2.55

2.71

mmol/l

12.88

2365

22876

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

103

3.03

7.46

1.6

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

103

3.03

7.46

1.6

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

428

1.94

7.32

1.4

1.7

0.42

0.85

g/l

5.95

346

(3010144) Erythrocytes [#/volume] in Synovial fluid

253

2.24

7.30

1.5

1.4

134789.81

65479.52

e6/l

0.28

180

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

145

898

1.65

7.28

1.5

1.6

16.12

17.79

u/ml

0.10

194

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

121

2.83

7.26

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

3.84

7.25

1.3

2.3

0.15

0.16

e9/l

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

105

2.97

7.23

1.6

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

123

731

1.71

7.21

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

102

575

1.80

7.18

4.6

1.8

0.87

0.88

nmol/l

0.04

484

(3042733) HLA Ab [Presence] in Serum

3.27

7.10

6.4

5.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

115

674

1.74

7.09

2.1

2.0

11.97

12.16

mg/l

0.07

108

624

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

108

624

1.76

7.01

2.6

2.3

201.80

113.29

ug/min

0.58

372

(3021589) Normoblasts [#/volume] in Blood

1277

11308

1.24

7.00

17.6

11.8

0.00

e9/l

0.34

1107

9200

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

133

815

1.66

6.97

1.6

1.5

1.21

9.49

iu/ml

0.49

144

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

141

2.65

6.97

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

123

1975

0.61

6.91

1.3

1.4

—

(40758558) Short blood count panel - Blood

916

7834

1.25

6.87

7.3

6.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

328

2.04

6.78

1.3

0.19

0.24

nmol/l

0.50

268

(3033099) Centromere Ab [Titer] in Serum

3.90

6.70

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

289

2.10

6.70

3.8

5.6

7.13

7.25

mmol/l

0.12

245

(3036670) Protein [Mass/volume] in Synovial fluid

3.18

6.56

1.4

1.3

44.59

38.38

g/l

1.60

(3036489) Thrombin time

141

892

1.61

6.54

2.6

1.9

20.53

21.32

0.96

127

797

(44816559) Phosphatidylethanol [Mass/volume] in Blood

159

1038

1.56

6.46

1.7

0.35

0.36

mg/l

0.02

516

(3008295) Osmolality of Serum or Plasma

288

2.07

6.38

1.3

278.98

275.33

mosm/kgh2o

0.55

218

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

278

2039

1.40

6.29

1.5

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

338

1.98

6.27

1.5

1.4

316.36

319.03

pmol/l

0.02

289

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

186

2.33

6.25

1.5

1.4

238.84

310.01

mu/l

2.68

145

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1091

9583

1.23

6.23

5.4

5.6

2.13

2.81

ug/l

2.10

995

8687

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

319

2.00

6.18

1.3

1.4

—

(3014271) Vancomycin [Susceptibility]

116

2.69

6.08

3.4

2.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

315

1.99

6.04

1.3

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

116

714

1.65

6.02

1.7

1.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

465

1.81

6.02

1.7

2.0

4.52

4.95

mmol/24h

0.59

409

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

111

2.72

6.01

1.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

111

2.72

6.01

1.1

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

209

2.22

5.98

1.3

1.1

—

50.76

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

215

1523

1.45

5.91

1.9

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

572

1.72

5.91

1.6

1.4

12.20

9.82

u/l

0.79

463

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

134

859

1.59

5.91

4.1

2.9

0.36

0.33

iu/ml

0.36

455

(3025468) Yersinia sp identified in Specimen by Organism specific culture

297

2.01

5.90

1.3

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.02

5.89

1.9

2.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

318

1.97

5.89

1.3

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

142

2.48

5.86

1.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

142

2.48

5.86

1.5

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

142

2.48

5.86

1.5

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

142

2.48

5.86

1.5

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

298

2.00

5.85

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

300

1.99

5.75

1.3

1.4

—

(3003181) Sodium [Moles/volume] in Urine

487

1.77

5.74

1.4

62.27

60.23

mmol/l

0.19

391

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.92

5.71

1.9

2.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

503

1.75

5.70

1.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

109

671

1.65

5.67

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

317

1.94

5.60

1.3

—

nmol/l

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

440

1.79

5.56

1.4

1.2

—

(3000012) Reticulocyte production index

411

1.82

5.55

2.1

2.2

0.93

0.04

276

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

380

2988

1.31

5.49

6.9

6.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

127

820

1.57

5.46

1.7

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

540

1.71

5.45

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

293

1.96

5.41

1.5

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

343

1.89

5.37

2.3

1.39

1.27

g/24h

0.11

202

(3028707) Methadone [Presence] in Urine by Screen method

239

2.07

5.37

2.7

2.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.10

5.34

1.2

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

319

1.90

5.17

1.4

1.5

22.39

31.52

ng/l

0.99

319

(4146454) Self-monitoring of blood glucose

312

1.91

5.17

2.6

2.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.24

5.17

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

235

1735

1.39

5.14

1.5

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

619

1.64

5.13

1.6

1.5

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

231

2.05

5.06

1.3

1.5

29.82

31.35

0.10

139

(3042631) Mycobacterium sp identified in Specimen

372

1.82

5.06

2.4

2.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

110

2.56

5.04

1.5

1.1

3.17

5.17

iu/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

294

1.92

5.02

1.5

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

609

1.63

4.96

1.1

3.48

4.11

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

441

1.74

4.96

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

123

2.45

4.96

1.8

1.6

1.96

2.32

u/field

0.21

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

532

1.68

4.95

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

275

1.95

4.93

1.6

1.7

—

(3049717) Cytology report of Urine Cyto stain

153

1053

1.48

4.92

2.4

2.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.67

4.91

1.2

1.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

130

2.40

4.89

1.6

2.6

893.23

1109.86

u/ml

0.31

130

(3032057) Clostridioides difficile [Presence] in Stool

3.35

4.88

1.7

2.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

490

1.69

4.83

1.6

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

226

1676

1.38

4.83

2.0

1.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

444

3621

1.27

4.82

1.5

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

617

5224

1.23

4.81

2.9

3.1

2.45

mmol/l

0.52

559

4711

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

157

2.24

4.75

1.9

1.6

6.83

6.55

u/l

0.06

134

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

418

1.74

4.71

1.1

43.18

66.09

iu/ml

0.27

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

525

1.66

4.68

1.6

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

178

2445

0.71

4.68

1.8

2.1

3.58

3.52

ratio

0.24

144

1953

(3006270) Folate [Moles/volume] in Blood

191

2.11

4.67

1.2

1.1

313.25

380.46

nmol/l

1.09

165

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.85

4.65

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1209

10937

1.18

4.62

2.2

1.9

1.44

1.37

mmol/l

1.74

994

9183

(3014148) Varicella zoster virus Ab [Titer] in Serum

269

1.91

4.54

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

200

2.07

4.54

1.1

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

439

1.70

4.50

1.3

1.2

287.57

264.86

u/ml

0.25

261

(40768443) Skin Pathology biopsy report

165

1174

1.43

4.49

1.3

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.87

4.49

1.5

0.62

0.36

ug/l

1.08

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

175

2.13

4.44

1.9

2.3

—

(3052851) Hemolysis interference index of Serum or Plasma

106

691

1.55

4.43

4.1

3.1

2.49

2.06

index

0.19

350

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

163

2.16

4.37

1.6

1.9

80.83

111.83

ng/l

1.75

163

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

122

1771

0.67

4.37

1.6

1.8

3.49

3.51

mmol/l

0.04

1272

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

437

1.69

4.31

1.7

1.4

165.27

156.92

au/ml

0.15

130

(3024928) Oxygen saturation in Venous blood

108

712

1.54

4.30

5.3

2.8

64.34

62.00

0.49

103

693

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.96

4.29

11.3

14.3

4.59

5.31

mmol/l

0.72

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.79

4.28

1.7

1.5

13.26

16.06

pmol/l

0.92

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

642

1.56

4.25

1.6

2.0

2.23

4.18

iu/l

4.18

252

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

114

764

1.51

4.22

2.9

2.0

96.89

92.03

1.51

109

738

(3020491) Glucose [Moles/volume] in Blood

159

2.15

4.21

1.6

1.9

6.76

6.86

mmol/l

0.08

101

(3016244) Insulin [Units/volume] in Serum or Plasma

127

2.30

4.19

2.5

2.9

29.16

20.73

mu/l

0.51

121

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

769

0.53

4.16

1.1

0.65

0.64

ratio

0.07

107

(3028192) IgG subclass 2 [Mass/volume] in Serum

249

1.90

4.16

1.3

1.5

2.48

2.97

g/l

1.40

186

(3027135) IgG subclass 1 [Mass/volume] in Serum

249

1.90

4.16

1.3

1.5

5.57

6.63

g/l

1.57

188

(3024139) IgG subclass 3 [Mass/volume] in Serum

249

1.90

4.16

1.3

1.5

0.42

0.38

g/l

0.30

186

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.25

4.14

1.8

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

126

867

1.47

4.11

2.3

2.4

0.00

0.02

g/l

1.65

111

774

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

101

664

1.54

4.09

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

195

2.01

4.08

1.2

101.51

106.06

pmol/l

0.22

195

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

8.02

4.06

1.3

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

356

2889

1.27

4.03

3.4

4.5

90.22

22.30

ug/l

0.42

304

2371

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

112

756

1.50

4.02

3.5

2.3

3.63

g/l

0.02

107

723

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.60

3.97

1.3

1.4

70.71

496.91

nmol/24h

0.65

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

2.82

3.95

2.0

1.2

25.62

28.61

0.15

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

503

1.61

3.94

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

503

1.61

3.94

1.4

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.73

3.92

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

105

704

1.51

3.90

1.6

1.3

—

(3028433) Virus identified in Specimen by Culture

2.64

3.89

1.1

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.64

3.89

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

100

2.41

3.89

1.1

1.0

—

(4062490) Immunoglobulin typing, IgG

248

1.87

3.89

1.3

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

105

705

1.51

3.88

3.6

2.3

202.35

198.21

0.17

669

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

398

1.67

3.83

2.4

1.9

87.41

3331.03

u/l

2.41

149

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

121

843

1.45

3.74

2.3

0.00

g/l

-0.00

104

732

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.51

3.71

3.0

29.06

29.35

umol/l

0.04

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

5.01

3.68

1.0

1.1

—

14.00

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

4.41

3.62

2.1

2.8

0.82

0.44

u/field

0.44

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.41

3.62

1.4

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

163

2.04

3.60

1.9

2.8

38.84

40.34

0.16

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

163

2.04

3.60

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

234

1.85

3.56

1.2

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

7.79

3.56

1.3

1.6

531.43

636.22

nmol/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

111

2.26

3.54

1.0

1397.48

1584.42

miu/ml

0.37

111

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

369

1.67

3.52

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.62

3.49

1.0

1.1

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

244

1.82

3.44

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

244

1.82

3.44

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

244

1.82

3.44

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

167

1.99

3.39

1.2

—

(40768446) Kidney Pathology biopsy report

107

2.25

3.38

1.8

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.58

3.38

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.58

3.38

1.2

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

691

6101

1.18

3.31

4.5

3.7

0.00

0.12

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

312

2552

1.25

3.31

3.7

2.5

32.41

56.77

u/l

0.70

268

2168

(3016750) Collection duration of Urine

155

2.01

3.29

2.5

2.1

527.14

493.54

min

0.79

110

(3006922) Hepatitis E virus Ab [Presence] in Serum

190

1.91

3.29

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

102

2.27

3.29

1.5

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

110

776

1.43

3.22

2.4

0.00

g/l

-0.00

104

731

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.34

3.22

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.34

3.22

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.18

3.19

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

164

1.96

3.19

1.1

1.0

825.58

731.50

ng/l

0.57

110

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

164

1.96

3.19

1.1

1.0

34.48

41.91

ng/l

0.56

112

(3030313) Adrenal Ab [Titer] in Serum

6.38

3.18

1.1

1.0

—

(3011288) Drugs identified in Urine by Screen method Nominal

397

1.60

3.14

2.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

827

0.61

3.13

1.2

1.53

g/l

0.02

827

(3035933) Granulocytes/Leukocytes in Blood

558

1.50

3.11

4.2

3.4

59.94

58.24

0.72

558

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.69

3.05

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.59

3.04

1.1

1.6

89.30

89.69

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.90

3.02

1.0

1.2

0.56

0.72

umol/24h

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.34

3.01

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

459

1.54

2.96

2.3

1.8

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.64

2.96

1.3

1.1

305.88

259.15

pmol/l

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

357

1.61

2.93

1.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

657

1.45

2.93

1.9

2.0

189.53

206.43

pmol/l

0.97

616

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

373

1.59

2.92

1.6

1.7

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

265

1.71

2.92

2.3

1.8

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

121

2.08

2.92

1.7

1.6

2.38

8.78

nmol/l

0.93

101

(3013139) Helicobacter pylori Ag [Presence] in Stool

213

1692

1.28

2.91

1.2

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

150

1.94

2.84

1.1

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

400

1.56

2.83

1.1

13.65

17.92

au/ml

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

283

1.67

2.83

1.6

1.3

1.07

1.49

nmol/l

2.31

262

(3023323) Follitropin [Units/volume] in Serum or Plasma

120

883

1.37

2.80

1.7

1.4

25.30

30.55

iu/l

1.09

101

762

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

165

1.89

2.80

1.1

1.0

345.43

323.18

ng/l

0.09

115

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

231

1.74

2.79

1.5

1.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.65

2.79

1.4

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

370

1.58

2.78

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.58

2.78

1.5

1.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.58

2.78

1.2

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

3.46

2.69

1.5

1.3

5.38

6.08

mmol/l

—

(3007566) Smooth muscle Ab [Titer] in Serum

103

745

1.40

2.68

1.1

1.2

61.25

106.90

titre

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.13

2.64

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.47

2.62

1.1

1.2

95.56

90.10

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

656

1.42

2.61

1.4

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

199

1.77

2.60

1.2

1.3

0.14

0.83

u/ml

1.50

114

(37208534) Antinuclear antibody arbitrary concentration in serum

2.23

2.54

1.1

1.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

662

1.40

2.49

1.4

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

232

1.69

2.49

4.3

3.4

18.70

12.05

index

1.04

133

(3052592) Norovirus Ag [Presence] in Stool

2.98

2.48

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.98

2.48

1.7

2.2

18.96

18.29

umol/l

0.05

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.38

2.47

1.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

210

1.72

2.46

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.90

2.41

1.1

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

150

1170

1.30

2.41

1.1

1.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

709

1.38

2.41

4.9

4.1

3.95

3.89

mmol/l

0.54

703

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.22

2.37

1.0

1.2

—

(3024932) HLA-DR beta [Type]

2.22

2.37

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

653

1.39

2.34

1.4

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

206

1.71

2.34

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

252

1.64

2.33

2.4

17.59

36.60

iu/ml

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

199

1.72

2.32

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

553

1.42

2.31

2.2

1.9

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.31

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.22

2.30

2.0

1.8

—

(3025577) Chromium [Mass/volume] in Blood

163

1.79

2.27

2.4

2.2

1.80

2.12

ug/l

0.31

142

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

193

1.72

2.26

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

156

1.80

2.25

1.3

1.4

1.10

1.24

nmol/l

0.26

108

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

294

1.57

2.25

1.2

1.0

3.36

2.35

eliau/ml

—

130

(3024471) HLA-A [Type]

2.16

2.24

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

335

1.53

2.22

4.3

5.9

341.14

358.77

umol/l

0.31

298

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

241

1.63

2.19

1.7

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.34

2.18

1.0

1.3

7.75

13.96

u/l

—

(40768800) Prostate Pathology biopsy report

648

0.64

2.17

1.1

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

151

1.80

2.16

1.6

1.2

17.45

22.32

u/l

0.50

127

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

151

1.80

2.16

1.2

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.01

2.14

1.0

—

(3012898) Urea [Moles/volume] in Urine

3.01

2.14

1.1

1.3

225.56

145.30

mmol/l

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

198

1.67

2.08

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

198

1.67

2.08

1.2

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

110

1.92

2.05

1.3

1.2

192.52

179.15

mmol/24h

0.26

110

(3021387) Prolactin [Units/volume] in Serum or Plasma

610

1.37

2.04

1.7

280.38

292.09

mu/l

0.12

569

(3000093) Morphology [Interpretation] in Blood Narrative

254

1.58

2.04

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

192

1.67

2.03

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.97

2.00

2.3

2.9

0.60

0.61

mmol/l

0.14

(44813793) Dust mix specific IgE antibody measurement

148

1.76

1.98

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

561

0.64

1.97

1.6

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

119

1.86

1.97

2.2

1.8

42.05

40.37

g/l

0.63

119

(3023511) Choriogonadotropin [Units/volume] in Urine

194

1.66

1.96

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

297

1.52

1.95

1.8

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

134

1.80

1.95

1.2

—

(40757373) Influenza virus identified in Isolate

2.45

1.93

1.5

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

157

1.73

1.92

1.6

1.2

68.45

85.30

u/l

0.81

134

(3018333) Ribosomal P Ab [Presence] in Serum

188

1.66

1.90

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

181

1.66

1.88

1.3

1.2

31.10

35.50

mmol/l

0.48

161

(3008536) Aspergillus sp Ab [Presence] in Serum

2.16

1.88

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

277

2380

1.18

1.87

2.7

2.3

12.95

13.43

nmol/l

0.41

246

2147

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.86

1.86

1.3

2.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.86

1.86

1.0

1.1

0.05

0.02

u/ml

—

(3000764) Benzodiazepines [Presence] in Urine

597

1.35

1.82

2.2

1.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

623

1.34

1.82

1.7

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

659

1.33

1.80

2.3

1.9

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

207

1.60

1.79

2.0

2.1

2.79

1.48

u/field

0.56

116

(3050129) First trimester maternal screen panel - Serum or Plasma

232

0.47

1.75

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

1.74

1.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

225

1.56

1.73

1.1

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

110

1.82

1.72

1.4

1.1

295.10

198.80

iu/ml

0.30

110

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

193

0.46

1.72

1.3

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.85

1.71

1.4

4.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

1.88

1.70

1.8

2.4

156.28

169.28

0.26

(4035726) Immunohistochemistry procedure

279

2419

1.17

1.70

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

176

0.45

1.69

1.4

1.6

—

(3027008) Opiates [Presence] in Urine

597

1.33

1.68

2.2

1.8

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

104

1.83

1.67

4.4

3.9

52.07

60.80

mg/l

0.33

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1940

19985

0.91

1.66

32.6

21.2

331.84

332.31

g/l

1.39

1932

19874

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.98

1.64

1.2

—

(3028300) Cannabinoids [Presence] in Urine

600

1.33

1.63

2.3

1.8

—

(3042951) Complement C1q Ab [Units/volume] in Serum

3.58

1.61

1.0

1.1

—

17.74

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

404

1.39

1.60

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

337

1.43

1.59

1.1

124.61

115.84

0.91

307

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

3.00

1.58

1.2

5.77

6.29

mmol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1080

0.77

1.57

1.7

1.8

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

631

1.31

1.55

3.0

3.6

1658.98

801.07

u/ml

0.39

589

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

257

1.49

1.53

1.5

1.3

38.10

31.97

u/l

0.46

210

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.34

1.52

1.4

5.9

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.60

1.51

1.3

1.9

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.86

1.50

1.2

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

108

1.76

1.50

1.2

1.3

—

(3027944) Amphetamines [Presence] in Urine

593

1.31

1.47

2.2

1.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

169

0.47

1.46

1.4

1.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.13

1.44

21.6

11.6

—

(40762887) Creatinine [Moles/volume] in Blood

3.13

1.44

1.4

1.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.13

1.44

1.2

1.1

—

(3017569) Oxygen content in Arterial blood

156

1.61

1.43

1.7

2.5

15.06

16.41

1.44

156

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.04

1.43

2.2

2.5

711.42

63.74

ug/l

0.42

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

278

1.45

1.42

1.4

0.30

0.33

nmol/l

0.10

203

(4198724) Urine methamphetamine measurement

1.94

1.38

4.6

1.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

164

0.49

1.35

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

159

1.58

1.34

1.8

2.2

8.28

8.78

mmol/l

0.23

159

(3022689) Creatine [Moles/volume] in Urine

1.78

1.33

1.3

1.4

7.73

8.78

mmol/l

0.29

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.50

1.30

1.7

1.5

53.17

47.67

umol/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.85

1.29

1.6

1.2

—

(21494434) Karyotype in Bone marrow

259

1.43

1.29

1.4

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

153

1.57

1.28

1.4

1.8

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.78

1.28

1.2

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

131

0.46

1.28

16.3

14.8

1049.00

822.28

nmol/l

—

124

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

319

1.39

1.27

1.0

1.1

3.27

3.03

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

536

1.29

1.27

5.4

3.3

32.12

27.50

mg/l

0.37

365

(4281824) Cell count and differential, peritoneal fluid

267

0.60

1.26

1.1

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.40

1.24

6.3

3.8

—

(3034426) Prothrombin time (PT)

1.86

1.24

1.2

1.3

27.08

29.65

0.94

(3024263) Appearance of Synovial fluid

131

1.61

1.23

2.0

1.7

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.00

1.23

6.7

6.8

8.97

10.50

—

(4133840) Spirometry

1.91

1.22

1.5

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.91

1.22

5.5

7.5

5.03

5.50

kpa

0.31

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.17

1.21

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

172

1.52

1.20

1.4

1.5

91.31

82.78

umol/l

0.36

172

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

289

1.39

1.19

3.0

3.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.83

1.19

1.6

1.4

11.28

8.81

ug/l

0.72

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.31

1.18

1.0

1.2

1.76

1.87

umol/24h

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

117

1.63

1.18

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

1.16

0.0

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.05

1.15

1.3

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.50

1.15

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.81

1.15

1.4

1.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

150

1.54

1.14

1.6

1.8

11.08

10.96

umol/l

0.01

(3005570) Glucose [Moles/volume] in Urine

233

1.42

1.13

2.4

2.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

543

5836

0.91

1.12

3.2

3.3

0.67

0.76

ug/l

1.90

369

3876

(3006462) Nitrate [Presence] in Urine

103

1.65

1.12

4.5

3.5

—

(4211845) Urine protein measurement

111

1.63

1.12

4.3

3.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.71

1.11

1.3

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.71

1.11

1.3

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.71

1.11

1.3

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.71

1.11

1.3

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

234

1.42

1.10

1.3

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

354

1.33

1.10

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

355

1.33

1.09

1.5

1.2

3.11

4.11

u/ml

0.45

161

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

193

0.57

1.07

1.3

1.4

142.35

209.64

pmol/l

0.45

193

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

795

1.21

1.06

2.5

1.9

—

(3002619) Bacteria identified in Specimen by Culture

1.93

1.06

2.1

1.2

—

(1761868) Lipid panel - Serum or Plasma

893

9382

0.93

1.05

4.1

3.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.71

1.05

2.8

4.98

4.90

kpa

0.12

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.71

1.05

2.8

9.96

10.27

kpa

0.23

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

162

1.49

1.04

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

2.27

1.03

1.0

1.1

—

(3019174) dRVVT (LA screen)

2.27

1.03

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.27

1.03

1.6

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

324

1.33

1.02

1.1

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.77

1.00

1.0

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.71

0.99

1.3

1.1

7.39

8.58

pmol/l

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

257

1.37

0.98

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.84

0.98

1.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.81

0.98

2.3

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.18

0.98

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

2.18

0.98

1.0

—

(3047189) Immunofixation for 24 hour Urine

140

1.50

0.97

1.4

1.6

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

124

1.54

0.96

1.1

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

199

1.41

0.95

1.6

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.65

0.94

1.1

1.5

3.31

3.17

mmol/l

0.06

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

357

1.29

0.91

1.6

1.2

6.19

4.18

u/ml

0.23

125

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.15

0.91

1.8

1.9

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

367

1.29

0.90

1.8

2.4

13342.44

99.59

u/ml

0.49

359

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.07

0.89

1.0

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.07

0.89

1.0

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.07

0.89

1.0

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

493

1.24

0.88

1.9

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

807

7696

1.07

0.86

4.6

4.5

21.45

21.72

0.20

384

3821

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

236

2136

1.11

0.85

2.7

2.8

64.22

65.30

ml/min/173m2

0.14

102

891

(3019832) Treponema pallidum Ab [Presence] in Serum

155

1367

1.14

0.85

1.6

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.61

0.81

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.82

0.79

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

348

1.27

0.78

1.1

—

(3045788) Cell count panel - Pleural fluid

293

0.71

0.78

1.7

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

150

0.60

0.78

1.6

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

131

1.45

0.78

3.9

4.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.62

0.78

1.0

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.62

0.78

1.9

2.6

212.08

181.93

0.20

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.77

0.0

1.0

—

(4195642) Thrombophilia screening test

332

1.27

0.76

1.2

—

(4034850) Laboratory test

780

1.17

0.75

12.9

9.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.60

0.74

1.5

1.0

—

(3034092) Cytoplasmic Ig cells/cells in Blood

2.09

0.74

9.4

12.8

0.14

0.20

—

(3050794) Legionella sp Ab [Presence] in Serum

2.09

0.74

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

227

1.33

0.74

3.6

3.1

16.49

38.24

mg/l

1.22

169

(4094501) Cardiovascular stress test using bicycle ergometer

782

1.17

0.74

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

506

1.21

0.73

3.3

3.5

0.77

0.80

nmol/l

0.32

414

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.58

0.71

1.6

1.5

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.92

0.70

1.4

1.7

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.85

0.68

1.0

1.1

0.02

0.16

u/ml

—

(3028717) Thiamine [Mass/volume] in Blood

1.67

0.68

1.1

1.3

71.71

65.90

ug/l

—

(4268621) Lupus anticoagulant assay

266

1.28

0.68

2.9

2.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

621

1.18

0.68

1.4

1.3

202.93

204.85

miu/ml

0.01

264

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

179

1.34

0.66

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

214

1.31

0.66

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.62

0.65

1.0

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.63

0.62

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.60

0.61

1.0

1.2

1.16

1.19

mmol/l

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

139

1.37

0.60

1.4

1.2

—

(3023419) Bacteria identified in Sputum by Culture

371

1.22

0.60

3.2

2.6

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

0.58

0.0

6.7

—

8.78

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.58

0.0

3.3

—

48.00

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

175

1.32

0.58

1.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.72

0.57

1.8

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.48

0.57

1.6

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

347

1.21

0.56

1.8

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

347

1.21

0.56

1.8

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

347

1.21

0.56

1.8

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

347

1.21

0.56

1.8

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

116

1043

1.12

0.54

2.7

3.6

1170.39

2382.03

u/ml

0.34

902

(3026051) Granulocytes/Leukocytes in Pleural fluid

1.43

0.52

1.6

1.4

40.11

24.68

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

134

0.67

0.51

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.41

0.50

1.1

1.0

—

(3002256) Pathology report gross observation

378

3608

1.06

0.43

1.4

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

841

1.11

0.42

1.6

1.8

3.52

4.44

mg/l

0.49

633

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.56

0.42

1.4

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

176

1.25

0.41

2.6

26.38

33.92

mg/l

0.54

131

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.52

0.41

1.4

1.0

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.52

0.41

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.52

0.41

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.52

0.41

7.8

6.1

16.40

60.19

ug/min

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.41

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

0.40

0.0

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

389

1.16

0.40

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.33

0.40

1.4

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.33

0.40

1.6

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

190

2018

0.94

0.36

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

289

0.83

0.36

1.9

1.5

6.77

6.30

mmol/l

0.48

271

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

281

1.18

0.36

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

126

1.27

0.35

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

340

1.15

0.33

1.8

1.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.67

0.32

1.7

2.4

164.83

146.37

nmol/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

119

1.26

0.31

1.2

1.1

—

(3025130) Human papilloma virus identified in Specimen

296

1.15

0.30

2.2

1.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

611

1.10

0.29

1.3

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.23

0.29

1.3

1.1

135.54

51.71

u/ml

—

(44806420) Estimation of glomerular filtration rate

280

1.14

0.27

3.6

2.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

521

1.10

0.25

1.2

47.05

36.31

u/l

0.28

444

(3010726) Horse dander IgE Ab [Units/volume] in Serum

340

0.88

0.25

1.2

1.1

0.84

1.20

u/ml

0.30

172

(3028308) Erythrocytes [#/volume] in Pleural fluid

313

1.12

0.23

1.6

1.4

200232.05

89506.38

e6/l

0.56

178

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

721

0.93

0.22

1.3

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.71

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

80.90

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

135

1.19

0.21

1.5

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

135

1.19

0.21

1.5

1.7

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.5

—

2.58

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.21

0.0

1.3

—

22.60

—

(40765096) Chromosome analysis panel by Banding

101

0.79

0.21

1.3

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3020650) Glucose [Presence] in Urine

1.24

0.21

2.1

2.0

0.00

0.07

estimate

0.80

(3024666) Lithium [Moles/volume] in Serum or Plasma

108

1.20

0.20

14.2

13.0

0.56

0.63

mmol/l

0.46

102

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

153

0.85

0.18

3.4

6.9

93.92

239.40

ug/l

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

125

1198

1.05

0.17

2.8

3.8

50.76

73.12

u/ml

0.62

119

1158

(3002523) Influenza virus A Ag [Presence] in Specimen

392

0.92

0.17

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

194

0.88

0.16

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.18

0.16

1.1

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

391

0.92

0.16

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

359

0.92

0.15

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.15

0.15

2.0

2.1

7.56

9.12

mg/l

—

(3044007) Cell count panel - Peritoneal fluid

0.78

0.14

1.4

2.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

150

1.13

0.14

1.2

1.1

42.30

18.06

u/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

354

0.93

0.12

1.1

0.18

1.46

u/ml

1.82

151

(3003888) Timothy IgE Ab [Units/volume] in Serum

364

0.93

0.11

1.1

1.38

3.77

u/ml

1.81

188

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

639

0.95

0.11

1.4

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

435

1.06

0.11

1.2

1.1

0.34

1.69

u/ml

3.65

238

(1002224) Polysomnography panel

122

1184

1.03

0.11

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.14

0.10

1.0

16.40

48.55

iu/ml

—

(3051101) Glucose [Moles/volume] in Cord blood

1.11

0.09

6.0

6.5

17.52

8.46

mmol/l

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

109

1062

1.03

0.08

1.3

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

322

1.06

0.08

2.2

3.6

12.38

23.32

nmol/l

0.26

315

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1997

20028

0.99

0.08

33.1

20.5

13.88

13.68

7.84

1983

19747

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.08

0.08

1.9

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

319

3149

1.01

0.08

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.83

0.07

1.0

1.6

—

0.54

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

122

0.90

0.07

1.1

1.2

11.91

9.61

mm/h

0.26

122

(40768795) Lymph node Pathology biopsy report

275

0.94

0.06

1.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.85

0.06

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

224

0.94

0.06

3.0

5.5

256.57

42.21

u/ml

—

(3012441) Differential panel - Pleural fluid

314

0.95

0.05

1.8

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

272

0.96

0.04

1.1

9.80

3.40

u/ml

—

113

(21494814) CD8 cells/Lymphocytes in Specimen

111

1.08

0.04

2.6

2.1

32.50

31.02

0.11

111

(3014133) Dog dander IgE Ab [Units/volume] in Serum

291

0.96

0.04

1.1

3.19

2.26

u/ml

0.30

137

(3020874) Milk IgE Ab [Units/volume] in Serum

121

1.07

0.03

1.0

1.1

0.25

1.00

u/ml

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

161

1.06

0.03

1.5

1.4

—

(40768793) Breast Pathology biopsy report

592

0.98

0.03

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

681

0.98

0.02

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

203

1.03

0.01

1.5

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

353

1.02

0.01

1.6

1.5

2029.59

4357.99

e6/l

0.44

238

(40768806) Pleura Pathology biopsy report

296

0.98

0.00

1.9

1.6

—

(40768441) Liver Pathology biopsy report

191

0.99

0.00

1.1

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

122

0.98

0.00

4.0

3.5

0.50

1.09

1.38

122

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.90

0.00

2.3

3.7

5.07

8.49

mg/l

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40758292) HTLV I+II Ab panel - Serum

1.00

-0.00

2.0

1.4

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

33.41

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

-0.00

0.0

1.7

—

793.00

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

4.25

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.75

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.4

—

44.21

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

1.40

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_NEUROOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_NEUROOTH	1.537 [1.37, 1.72]	< 0.001
Birth year	0.994 [0.98, 1.0]	0.136

During the follow-up period (1.1.1998 — 31.12.2019), 1028 out of 5356 females with G6_NEUROOTH died.

Males

Parameter	HR [95% CI]	p-value
G6_NEUROOTH	1.566 [1.4, 1.75]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 1427 out of 6181 males with G6_NEUROOTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_NEUROOTH.

N-year risk	Females	Males
1	0.143%	0.305%
5	0.884%	1.664%
10	2.071%	4.471%
15	4.006%	8.346%
20	6.955%	13.924%

Relationships between endpoints

↥

Index endpoint: G6_NEUROOTH – Other disorders of nervous system

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other disorders of nervous system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints